Document:

Exhibit 4.5
 

INVESTORS’ RIGHTS AGREEMENT

 

by and
among, on the one hand, 

 

GAMEPLAN, INC., a Nevada corporation

 

and

 

KEY HOLDERS AS LISTED HEREIN

 

and

 

 

KGPLA HOLDINGS LLC, AS THE LEAD
INVESTOR, AND THE OTHER INVESTORS LISTED HEREIN

 

dated as of

 

 

January______, 2020

 

 

    	 	1	 

     

    

 

TABLE OF CONTENTS

 

 

	1.	DEFINITIONS	1
	2.	REGISTRATION RIGHTS	4
	 	2.1	Demand Registration	4
	 	2.2	Company Registration	5
	 	2.3	Underwriting Requirements	6
	 	2.4	Obligations of the Company	7
	 	2.5	Furnish Information	8
	 	2.6	Expenses of Registration	8
	 	2.7	Delay of Registration	8
	 	2.8	Indemnification	8
	 	2.9	Reports Under Exchange Act	10
	 	2.10	Limitations on Subsequent Registration Rights	10
	 	2.11	“Market Stand-off” Agreement	11
	 	2.12	Restrictions on Transfer	11
	 	2.13	Termination of Registration Rights	12
	3.	INFORMATION AND OBSERVER RIGHTS	12
	 	3.1	Delivery of Financial Statements	12
	 	3.2	Inspection	13
	 	3.3	Termination of Information	13
	 	3.4	Confidentiality	14
	 	4.	RIGHTS TO FUTURE STOCK ISSUANCES	14
	 	4.1	Right of First Offer	14
	 	4.2	Termination	15
	5.	ADDITIONAL COVENANTS	15
	 	5.1	Insurance	15
	 	5.2	Employee Agreements	15
	 	5.3	Employee Stock	15
	 	5.4	Matters Requiring Investor Director Approval	15
	 	5.5	Board Matters	16
	 	5.6	Successor Indemnification	16
	 	5.7	Expenses of Counsel	17
	 	5.8	Indemnification Matters	17
	 	5.9	Cybersecurity	17
	 	5.10	Termination of Covenants	18

 

 

    	 	2	 

     

    

 

	6.	MISCELLANEOUS	18
	 	6.1	Successors and Assigns	18
	 	6.2	Governing Law	18
	 	6.3	Counterparts	18
	 	6.4	Titles and Subtitles	18
	 	6.5	Notices	18
	 	6.6	Amendments and Waivers	19
	 	6.7	Severability	19
	 	6.8	Aggregation of Stock	19
	 	6.9	Additional Investors	20
	 	6.10	Entire Agreement	20
	 	6.11	Dispute Resolution	20
	 	6.12	Delays or Omissions	20

 

  

 

 

 

 

 

 

 

    	 	3	 

     

    

 

EXHIBIT G TO SECURITIES PURCHASE AGREEMENT

 

INVESTORS’ RIGHTS AGREEMENT

 

THIS INVESTORS’
RIGHTS AGREEMENT (this “Agreement”), is made as of the January , 2020, by and among GamePlan, Inc., a Nevada corporation
(the “Company”), the Lead Investor and each of the investors listed on Schedule A, each of which together with
the Lead Investor is referred to in this Agreement as an “Investor”, and each of the stockholders listed on Schedule
B, each of whom is referred to herein as a “Key Holder”, and any Additional Investor (as defined in that certain
Securities Purchase Agreement dated of even date herewith (the “Purchase Agreement”)) that becomes a party to this
Agreement in accordance with Section 6.9. Capitalized terms used but not otherwise defined herein shall have the meanings set forth in
the Purchase Agreement.

 

RECITALS

 

WHEREAS, the Company and the Investors are parties
to the Purchase Agreement; and

 

WHEREAS,
in order to induce the Company to enter into the Purchase Agreement and to induce the Investors to invest funds in the Company pursuant
to the Purchase Agreement, the Investors and the Company hereby agree that this Agreement shall govern the rights of the Investors to
cause the Company to register shares of Common Stock issuable to the Investors upon conversion of any Convertible Debentures purchased
under the Purchase Agreement, to receive certain information from the Company, and to participate in future equity offerings by the Company,
and shall govern certain other matters as set forth in this Agreement.

 

NOW, THEREFORE, the parties hereby agree as follows:

 

1.              
Definitions. For purposes of this Agreement:

 

1.1                            
“Affiliate” means, with respect to any specified Person, any other Person who, directly or indirectly, controls,
is controlled by, or is under common control with such Person, including without limitation any general partner, managing member, officer,
director or trustee of such Person, or any venture capital fund or registered investment company now or hereafter existing that is controlled
by one or more general partners, managing members or investment adviser of, or shares the same management company or investment adviser
with, such Person.

 

1.2                            
“Amended Articles” means the Company’s Amended and Restated Articles of Incorporation, as amended
and/or restated from time to time.

 

1.3                            
“Board of Directors” means the board of directors of the Company.

 

1.4                            
“Common Stock” means shares of the Company’s common stock, par value $0.001

per share.

 

1.5                            
“Competitor” means a Person engaged, directly or indirectly (including through any partnership, limited
liability company, corporation, joint venture or similar arrangement (whether now existing or formed hereafter)), in cryptocurrency, but
shall not include any financial investment firm or collective investment vehicle that, together with its Affiliates, holds less than twenty
percent (20)% of the outstanding equity of any Competitor and does not, nor do any of its Affiliates, have a right to designate any members
of the board of directors of any Competitor.

 

1.6                            
“Damages” means any loss, damage, claim or liability (joint or several) to which a party hereto may become
subject under the Securities Act, the Exchange Act, or other federal or state law, insofar as such loss, damage, claim or liability (or
any action in respect thereof) arises out of or is based upon: (i) any untrue statement or alleged untrue statement of a material fact
contained in any registration statement of the Company, including any preliminary prospectus or final prospectus contained therein or
any amendments or supplements thereto; (ii) an omission or alleged omission to state therein a material fact required to be stated therein,
or necessary

to make the statements therein not
misleading; or (iii) any violation or alleged violation by the indemnifying party (or any of its agents or Affiliates) of the Securities
Act, the Exchange Act, any state securities law, or any rule or regulation promulgated under the Securities Act, the Exchange Act, or
any state securities law.

 

 

    	 	4	 

     

    

 

1.7                            
“Derivative Securities” means any securities or rights convertible into, or exercisable or exchangeable
for (in each case, directly or indirectly), Common Stock, including options and warrants.

 

1.8                            
“Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated
thereunder.

 

1.9                            
“Excluded Registration” means (i) a registration relating to the sale or grant of securities to employees
of the Company or a subsidiary pursuant to a stock option, stock purchase, equity incentive or similar plan; (ii) a registration relating
to an SEC Rule 145 transaction; (iii) a registration on any form that does not include substantially the same information as would be
required to be included in a registration statement covering the sale of the Registrable Securities; or (iv) a registration in which the
only Common Stock being registered is Common Stock issuable upon conversion of debt securities that are also being registered.

 

1.10                         
“Form S-1” means such form under the Securities Act as in effect on the date hereof or any successor registration
form under the Securities Act subsequently adopted by the SEC.

 

1.11                         
“Form S-3” means such form under the Securities Act as in effect on the date hereof or any registration
form under the Securities Act subsequently adopted by the SEC that permits forward incorporation of substantial information by reference
to other documents filed by the Company with the SEC.

 

1.12                         
“GAAP” means generally accepted accounting principles in the United States as in effect from time to time.

 

1.13                         
“Holder” means any holder of Registrable Securities who is a party to this

Agreement.

 

1.14                         
“Immediate Family Member” means a child, stepchild, grandchild, parent, stepparent, grandparent, spouse,
sibling, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law, including, adoptive relationships,
of a natural person referred to herein.

 

1.15                         
“Initiating Holders” means, collectively, Holders who properly initiate a registration request under this
Agreement.

 

1.16                         
“IPO” means the Company’s first underwritten public offering of its Common Stock under the Securities
Act.

1.17                         
“Key Employee” means any executive-level employee (including, division director and vice president-level
positions) as well as any employee who, either alone or in concert with others, develops, invents, programs, or designs any Company Intellectual
Property (as defined in the Purchase Agreement).

 

1.18                         
“Key Holder Registrable Securities” means (i) the shares of Common Stock held by the Key Holders, and (ii)
any Common Stock issued as (or issuable upon the conversion or exercise of any warrant, right, or other security that is issued as) a
dividend or other distribution with respect to, or in exchange for or in replacement of such shares.

 

 

    	 	5	 

     

    

 

1.19                         
“Lead Investor Director” means any director of the Company that the Lead Investor is entitled to elect,
exclusively and as a separate class, pursuant to the Amended Articles and/or the Voting Agreement.

 

1.20                         
“Listing” means the listing of the Company’s securities pursuant to a Registration Statement, on any
exchange and anywhere in the world.

 

1.21                         
“Major Investor” means the Lead Investor and any Investor that, individually or together with such Investor’s
Affiliates, holds at least thirty percent (30%) of the shares of Registrable Securities (as adjusted for any stock split, stock dividend,
combination, or other recapitalization or reclassification effected after the date hereof).

 

1.22                         
“New Securities” means, collectively, equity securities of the Company, whether or not currently authorized,
as well as rights, options, or warrants to purchase such equity securities, or securities of any type whatsoever that are, or may become,
convertible or exchangeable into or exercisable for such equity securities.

 

1.23                         
“Person” means any individual, corporation, partnership, trust, limited liability company, association or
other entity.

 

1.24                         
“Registrable Securities” means (i) the Common Stock issuable or issued upon conversion of the Convertible
Debentures; (ii) any Common Stock, or any Common Stock issued or issuable (directly or indirectly) upon conversion and/or exercise of
any other securities of the Company, acquired by the Investors after the date hereof; and (iii) any Common Stock issued as (or issuable
upon the conversion or exercise of any warrant, right, or other security that is issued as) a dividend or other distribution with respect
to, or in exchange for or in replacement of, the shares referenced in clauses (i) and (ii) above; excluding in all cases, however, any
Registrable Securities sold by a Person in a transaction in which the applicable rights under this Agreement are not assigned pursuant
to Section 6.1, and excluding for purposes of Section 2 any shares for which registration rights have terminated pursuant to Section 2.13
of this Agreement.

 

1.25                         
“Registrable Securities then outstanding” means the number of shares determined by adding the number of
shares of outstanding Common Stock that are Registrable Securities and the number of shares of Common Stock issuable (directly or indirectly)
pursuant to then exercisable and/or convertible securities that are Registrable Securities.

 

1.26                         
“Restricted Securities” means the securities of the Company required to be notated with the legend set forth
in Section 2.12(b).

 

1.27                         
“Registration Statement” means the registration statement required with respect to a Listing of securities
for offer and sale to the public pursuant to the laws, rules and regulations of the applicable jurisdiction and governmental or quasi-governmental
authority responsible for regulating such securities as offered, sold and listed on the applicable publicly accessible exchange for trading
in such securities, anywhere in the world.

 

1.28                         
“Sale of the Company” means a transaction or series of related transactions in which a Person, or a group
of related Persons, acquires from Holders Common Stock or other Registrable Securities representing more than fifty percent (50%) of the
outstanding voting power of the Company, or substantially all of the assets of the Company.

 

1.29                         
“SEC” means the Securities and Exchange Commission.

 

1.30                         
“SEC Rule 144” means Rule 144 promulgated by the SEC under the Securities Act.

 

 

    	 	6	 

     

    

 

1.31                         
“SEC Rule 145” means Rule 145 promulgated by the SEC under the Securities Act.

 

1.32                         
“Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated
thereunder.

 

1.33                         
“Selling Expenses” means all underwriting discounts, selling commissions, and stock transfer taxes applicable
to the sale of Registrable Securities, and fees and disbursements of counsel for any Holder, except for the fees and disbursements of
the Selling Holder Counsel borne and paid by the Company as provided in Section 2.6.

 

2.              
Registration Rights. The Company covenants and agrees as follows:

 

2.1           
Demand Registration.

 

(a)            
If at any time after the earlier of (i) five (5) years after the date of this Agreement or (ii) one hundred eighty (180) days
after the effective date of the Registration Statement for any Listing, the Company receives a request from either the Lead Investor
or Holders of thirty percent (30%) of the Registrable Securities then outstanding, and only upon such request in their sole discretion,
that the Company file the appropriate registration statement with respect to at least thirty percent (30%) of the Registrable Securities
then outstanding (or a lesser percent if the anticipated aggregate offering price, net of Selling Expenses, would exceed $15 million),
then the Company shall (x) within ten (10) days after the date such request is given, give notice thereof (the “Demand Notice”)
to all Holders other than the Initiating Holders; and (y) as soon as practicable, and in any event within sixty (60) days after the date
such request is given by the Initiating Holders, file the appropriate registration statement under the Securities Act and/or other laws,
rules and regulations covering all Registrable Securities with respect to the Listing that the Initiating Holders requested to be registered
and any additional Registrable Securities requested to be included in such registration by any other Holders, as specified by notice
given by each such Holder to the Company within twenty (20) days of the date the Demand Notice is given, and in each case, subject to
the limitations of Sections 2.1(d) and 2.3.

 

(b)            
If at any time after the earlier of (i) five (5) years after the date of this Agreement or (ii) one hundred eighty (180) days
after the effective date of the Registration Statement for an IPO, the Company receives a request from either the Lead Investor or Holders
of thirty percent (30%) of the Registrable Securities then outstanding that the Company file a Form S-1 registration statement with respect
to at least thirty percent (30%) of the Registrable Securities then outstanding (or a lesser percent if the anticipated aggregate offering
price, net of Selling Expenses, would exceed $15 million), then the Company shall (x) within ten (10) days after the date such request
is given, give a Demand Notice to all Holders other than the Initiating Holders; and (y) as soon as practicable, and in any event within
sixty (60) days after the date such request is given by the Initiating Holders, file a Form S-1 registration statement under the Securities
Act covering all Registrable Securities that the Initiating Holders requested to be registered and any additional Registrable Securities
requested to be included in such registration by any other Holders, as specified by notice given by each such Holder to the Company within
twenty (20) days of the date the Demand Notice is given, and in each case, subject to the limitations of Sections 2.1(d) and 2.3.

 

(c)            
If at any time when it is eligible to use a Form S-3 registration statement, the Company receives a request from Holders of at
least thirty-five percent (35%) of the Registrable Securities then outstanding that the Company file a Form S-3 registration statement
with respect to outstanding Registrable Securities of such Holders having an anticipated aggregate offering price, net of Selling Expenses,
of at least $5 million, then the Company shall (i) within ten (10) days after the date such request is given, give a Demand Notice to
all Holders other than the Initiating Holders; and (ii) as soon as practicable, and in any event within forty-five (45) days after the
date such request is given by the Initiating Holders, file a Form S-3 registration statement under the Securities Act covering all Registrable
Securities requested to be included in such registration by any other Holders, as specified by notice given by each such Holder to the
Company within twenty (20) days of the date the Demand Notice is given, and in each case, subject to the limitations of Sections 2.1(d)
and 2.3.

 

 

    	 	7	 

     

    

 

(d)            
Notwithstanding the foregoing obligations, if the Company furnishes to Holders requesting a registration pursuant to this Section
2.1 a certificate signed by the Company’s chief executive officer stating that in the good faith judgment of the Board of Directors
it would be materially detrimental to the Company and its stockholders for such registration statement to either become effective or remain
effective for as long as such registration statement otherwise would be required to remain effective, because such action would (i) materially
interfere with a significant acquisition, corporate reorganization, or other similar transaction involving the Company; (ii) require premature
disclosure of material information that the Company has a bona fide business purpose for preserving as confidential; or (iii) render the
Company unable to comply with requirements under the Securities Act or Exchange Act, then the Company shall have the right to defer taking
action with respect to such filing, and any time periods with respect to filing or effectiveness thereof shall be tolled correspondingly,
for a period of not more than ninety (90) days after the request of the Initiating Holders is given; provided, however, that the Company
may not invoke this right more than once in any twelve (12) month period; and provided further that the Company shall not register any
securities for its own account or that of any other stockholder during such ninety (90)-day period other than an Excluded Registration.

 

(e)            
The Company shall not be obligated to effect, or to take any action to effect, any registration pursuant to Section 2.1(a): (i)
during the period that is sixty (60) days before the Company’s good faith estimate of the date of filing of, and ending on a date
that is one hundred eighty (180) days after the effective date of, a Company-initiated registration, provided that the Company is actively
employing in good faith commercially reasonable efforts to cause such registration statement to become effective; (ii) after the Company
has effected one (1)  registration pursuant to
Section 2.1(a); or (iii) if the Initiating Holders propose to dispose of shares of Registrable Securities that may be immediately registered
on Form S-3 pursuant to a request made pursuant to Section 2.1(c). The Company shall not be obligated to effect, or to take any action
to effect, any registration pursuant to Section 2.1(c): (i) during the period that is thirty (30) days before the Company’s good
faith estimate of the date of filing of, and ending on a date that is ninety (90) days after the effective date of, a Company-initiated
registration, provided that the Company is actively employing in good faith commercially reasonable efforts to cause such registration
statement to become effective; or (ii) if the Company has effected two (2) registrations pursuant to Section 2.1(c) within the twelve
(12) month period immediately preceding the date of such request. A registration shall not be counted as “effected” for purposes
of this Section 2.1(e) until such time as the applicable registration statement has been declared effective by the SEC, unless the Initiating
Holders withdraw their request for such registration, elect not to pay the registration expenses therefor, and forfeit their right to
one demand registration statement pursuant to Section 2.6, in which case such withdrawn registration statement shall be counted as “effected”
for purposes of this Section 2.1(e); provided, that if such withdrawal is during a period the Company has deferred taking action pursuant
to Section 2.1(d), then the Initiating Holders may withdraw their request for registration and such registration will not be counted
as “effected” for purposes of this Section 2.1(e).

 

(f)             
Nothing in this Agreement is intended to prohibit the Company from preparing its Common Stock to trade on the OTC Markets platform
as an OTC Pink Current Information company, or better, on the OTC Pink (Pink Open Market) or OTCQB without Shell, Caveat Emptor, or Stop
qualifiers; provided, however, as long as any such action, in one or more series of actions, alone or in the aggregate, does not materially
adversely affect the rights of the Lead Investor and the Holders including, without limitation the Securities or the Registrable Securities
as held by it or them.

 

2.2           
Company Registration. If the Company proposes to register (including, for this purpose, a registration effected by the Company
for stockholders other than the Holders) any of its securities under the Securities Act in connection with the public offering of such
securities solely for cash (other than in an Excluded Registration), the Company shall, at such time, promptly give each Holder notice
of such registration. Upon the request of each Holder given within twenty (20) days after such notice is given by the Company, the Company
shall, subject to the provisions of Section 2.3, cause to be registered all of the Registrable Securities that each such Holder has requested
to be included in such registration. The Company shall have the right to terminate or withdraw any registration initiated by it under
this Section 2.2 before the effective date of such registration, whether or not any Holder has elected to include Registrable Securities
in such registration. The expenses (other than Selling Expenses) of such withdrawn registration shall be borne by the Company in accordance
with Section 2.6.

 

 

    	 	8	 

     

    

 

2.3           
Underwriting Requirements.

 

(a)            
If, pursuant to Section 2.1, the Initiating Holders intend to distribute the Registrable Securities covered by their request by
means of an underwriting, they shall so advise the Company as a part of their request made pursuant to Section 2.1, and the Company shall
include such information in the Demand Notice. The underwriter(s) will be selected by the Board of Directors and shall be reasonably acceptable
to a majority in interest of the Initiating Holders. In such event, the right of any Holder to include such Holder’s Registrable
Securities in such registration shall be conditioned upon such Holder’s participation in such underwriting and the inclusion of
such Holder’s Registrable Securities in the underwriting to the extent provided herein. All Holders proposing to distribute their
securities through such underwriting shall (together with the Company as provided in Section 2.4(e)) enter into an underwriting agreement
in customary form with the underwriter(s) selected for such underwriting. Notwithstanding any other provision of this Section 2.3, if
the managing underwriter(s) advise(s) the Initiating Holders in writing that marketing factors require a limitation on the number of shares
to be underwritten, then the Initiating Holders shall so advise all Holders of Registrable Securities that otherwise would be underwritten
pursuant hereto, and the number of Registrable Securities that may be included in the underwriting shall be allocated among such Holders
of Registrable Securities, including the Initiating Holders, in proportion (as nearly as practicable) to the number of Registrable Securities
owned by each Holder or in such other proportion as shall mutually be agreed to by all such selling Holders; provided, however, that the
number of Registrable Securities held by the Holders to be included in such underwriting shall not be reduced unless all other securities
are first entirely excluded from the underwriting.

 

(b)            
In connection with any offering involving an underwriting of shares of the Company’s capital stock pursuant to Section 2.2,
the Company shall not be required to include any of the Holders’ Registrable Securities in such underwriting unless the Holders
accept the terms of the underwriting as agreed upon between the Company and its underwriters, and then only in such quantity as the underwriters
in their sole discretion determine will not jeopardize the success of the offering by the Company. If the total number of securities,
including Registrable Securities, requested by stockholders to be included in such offering exceeds the number of securities to be sold
(other than by the Company) that the underwriters in their reasonable discretion determine is compatible with the success of the offering,
then the Company shall be required to include in the offering only that number of such securities, including Registrable Securities,
which the underwriters and the Company in their sole discretion determine will not jeopardize the success of the offering. If the underwriters
determine that less than all of the Registrable Securities requested to be registered can be included in such offering, then the Registrable
Securities that are included in such offering shall be allocated among the selling Holders in proportion (as nearly as practicable to)
the number of Registrable Securities owned by each selling Holder or in such other proportions as shall mutually be agreed to by all
such selling Holders. Notwithstanding the foregoing, in no event shall (i) the number of Registrable Securities included in the offering
be reduced unless all other securities (other than securities to be sold by the Company) are first entirely excluded from the offering,
or (ii) the number of Registrable Securities included in the offering be reduced below twenty-five percent (25%) of the total number
of securities included in such offering, unless such offering is the IPO, in which case the selling Holders may be excluded further if
the underwriters make the determination described above and no other stockholder’s securities are included in such offering, or
(iii) notwithstanding (ii) above, any Registrable Securities which are not Key Holder Registrable Securities be excluded from such underwriting
unless all Key Holder Registrable Securities are first excluded from such offering. For purposes of the provision in this Section 2.3(b)
concerning apportionment, for any selling Holder that is a partnership, limited liability company, or corporation, the partners, members,
retired partners, retired members, stockholders, and Affiliates of such Holder, or the estates and Immediate Family Members of any such
partners, retired partners, members, and retired members and any trusts for the benefit of any of the foregoing Persons, shall be deemed
to be a single “selling Holder,” and any pro rata reduction with respect to such “selling Holder” shall be based
upon the aggregate number of Registrable Securities owned by all Persons included in such “selling Holder,” as defined in
this sentence.

 

 

    	 	9	 

     

    

 

2.4           
Obligations of the Company. Whenever required under this Section 2 to effect the registration of any Registrable Securities,
the Company shall, as expeditiously as reasonably possible:

 

(a)            
prepare and file with the SEC a registration statement with respect to such Registrable Securities and use its commercially reasonable
efforts to cause such registration statement to become effective and, upon the request of the Holders of a majority of the Registrable
Securities registered thereunder, keep such registration statement effective for a period of up to one hundred twenty (120) days or, if
earlier, until the distribution contemplated in the registration statement has been completed; provided, however, that (i) such one hundred
twenty (120) day period shall be extended for a period of time equal to the period the Holder refrains, at the request of an underwriter
of Common Stock (or other securities) of the Company, from selling any securities included in such registration, and (ii) in the case
of any registration of Registrable Securities on Form S-3 that are intended to be offered on a continuous or delayed basis, subject to
compliance with applicable SEC rules, such one hundred twenty (120) day period shall be extended for up to sixty (60) days, if necessary,
to keep the registration statement effective until all such Registrable Securities are sold;

 

(b)            
prepare and file with the SEC such amendments and supplements to such registration statement, and the prospectus used in connection
with such registration statement, as may be necessary to comply with the Securities Act in order to enable the disposition of all securities
covered by such registration statement;

 

(c)            
furnish to the selling Holders such numbers of copies of a prospectus, including a preliminary prospectus, as required by the Securities
Act, and such other documents as the Holders may reasonably request in order to facilitate their disposition of their Registrable Securities;

 

(d)            
use its commercially reasonable efforts to register and qualify the securities covered by such registration statement under such
other securities or blue-sky laws of such jurisdictions as shall be reasonably requested by the selling Holders; provided that the Company
shall not be required to qualify to do business or to file a general consent to service of process in any such states or jurisdictions,
unless the Company is already subject to service in such jurisdiction and except as may be required by the Securities Act;

 

(e)            
in the event of any underwritten public offering, enter into and perform its obligations under an underwriting agreement, in usual
and customary form, with the underwriter(s) of such offering;

 

(f)             
use its commercially reasonable efforts to cause all such Registrable Securities covered by such registration statement to be listed
on a national securities exchange or trading system and each securities exchange and trading system (if any) on which similar securities
issued by the Company are then listed;

 

(g)            
provide a transfer agent and registrar for all Registrable Securities registered pursuant to this Agreement and provide a CUSIP
number for all such Registrable Securities, in each case not later than the effective date of such registration;

 

(h)            
promptly make available for inspection by the selling Holders, any managing underwriter(s) participating in any disposition pursuant
to such registration statement, and any attorney or accountant or other agent retained by any such underwriter or selected by the selling
Holders, all financial and other records, pertinent corporate documents, and properties of the Company, and cause the Company’s
officers, directors, employees, and independent accountants to supply all information reasonably requested by any such seller, underwriter,
attorney, accountant, or agent, in each case, as necessary or advisable to verify the accuracy of the information in such registration
statement and to conduct appropriate due diligence in connection therewith;

 

 

    	 	10	 

     

    

 

(i)             
notify each selling Holder, promptly after the Company receives notice thereof, of the time when such registration statement has
been declared effective or a supplement to any prospectus forming a part of such registration statement has been filed; and

 

(j)             
after such registration statement becomes effective, notify each selling Holder of any request by the SEC that the Company amend
or supplement such registration statement or prospectus.

 

In addition, the Company shall ensure
that, at all times after any registration statement covering a public offering of securities of the Company under the Securities Act shall
have become effective, its insider trading policy shall provide that the Company’s directors may implement a trading program under
Rule 10b5-1 of the Exchange Act.

 

2.5           
Furnish Information. It shall be a condition precedent to the obligations of the Company to take any action pursuant to this
Section 2 with respect to the Registrable Securities of any selling Holder that such Holder shall furnish to the Company such information
regarding itself, the Registrable Securities held by it, and the intended method of disposition of such securities as is reasonably required
to effect the registration of such Holder’s Registrable Securities.

 

2.6           
Expenses of Registration. All expenses (other than Selling Expenses) incurred in connection with registrations, filings, or
qualifications pursuant to this Section 2, including all registration, filing, and qualification fees; printers’ and accounting
fees; fees and disbursements of counsel for the Company; and the reasonable fees and disbursements, not to exceed $100,000.00 of one counsel
for the selling Holders (“Selling Holder Counsel”), shall be borne and paid by the Company; provided, however, that
the Company shall not be required to pay for any expenses of any registration proceeding begun pursuant to Section 2.1 if the registration
request is subsequently withdrawn at the request of the Holders of a majority of the Registrable Securities to be registered (in which
case all selling Holders shall bear such expenses pro rata based upon the number of Registrable Securities that were to be included in
the withdrawn registration), unless the Holders of a majority of the Registrable Securities agree to forfeit their right to one registration
pursuant to Sections 2.1(a) or 2.1(c), as the case may be; provided further that if, at the time of such withdrawal, the Holders shall
have learned of a material adverse change in the condition, business, or prospects of the Company from that known to the Holders at the
time of their request and have withdrawn the request with reasonable promptness after learning of such information then the Holders shall
not be required to pay any of such expenses and shall not forfeit their right to one registration pursuant to Sections 2.1(a) or 2.1(c).
All Selling Expenses relating to Registrable Securities registered pursuant to this Section 2 shall be borne and paid by the Holders pro
rata on the basis of the number of Registrable Securities registered on their behalf.

 

2.7           
Delay of Registration. No Holder shall have any right to obtain or seek an injunction restraining or otherwise delaying any
registration pursuant to this Agreement as the result of any controversy that might arise with respect to the interpretation or implementation
of this Section 2.

 

2.8           
Indemnification. If any Registrable Securities are included in a registration statement under this Section 2:

 

(a)            
To the extent permitted by law, the Company will indemnify and hold harmless each selling Holder, and the partners, members, officers,
directors, and stockholders of each such Holder; legal counsel and accountants for each such Holder; any underwriter (as defined in the
Securities Act) for each such Holder; and each Person, if any, who controls such Holder or underwriter within the meaning of the Securities
Act or the Exchange Act, against any Damages, and the Company will pay to each such Holder, underwriter, controlling Person, or other
aforementioned Person any legal or other expenses reasonably incurred thereby in connection with investigating or defending any claim
or proceeding from which Damages may result, as such expenses are incurred; provided, however, that the indemnity agreement contained
in this Section 2.8(a) shall not apply to amounts paid in settlement of any such claim or proceeding if such settlement is effected without
the consent of the Company, which consent shall not be unreasonably withheld, nor shall the Company be liable for any Damages to the
extent that they arise out of or are based upon actions or omissions made in reliance upon and in conformity with written information
furnished by or on behalf of any such Holder, underwriter, controlling Person, or other aforementioned Person expressly for use in connection
with such registration.

 

 

    	 	11	 

     

    

 

(b)            
To the extent permitted by law, each selling Holder, severally and not jointly, will indemnify and hold harmless the Company, and
each of its directors, each of its officers who has signed the registration statement, each Person (if any), who controls the Company
within the meaning of the Securities Act, legal counsel and accountants for the Company, any underwriter (as defined in the Securities
Act), any other Holder selling securities in such registration statement, and any controlling Person of any such underwriter or other
Holder, against any Damages, in each case only to the extent that such Damages arise out of or are based upon actions or omissions made
in reliance upon and in conformity with written information furnished by or on behalf of such selling Holder expressly for use in connection
with such registration; and each such selling Holder will pay to the Company and each other aforementioned Person any legal or other expenses
reasonably incurred thereby in connection with investigating or defending any claim or proceeding from which Damages may result, as such
expenses are incurred; provided, however, that the indemnity agreement contained in this Section 2.8(b) shall not apply to amounts paid
in settlement of any such claim or proceeding if such settlement is effected without the consent of the Holder, which consent shall not
be unreasonably withheld; and provided further that in no event shall the aggregate amounts payable by any Holder by way of indemnity
or contribution under Sections 2.8(b) and 2.8(d) exceed the proceeds from the offering received by such Holder (net of any Selling Expenses
paid by such Holder), except in the case of fraud or willful misconduct by such Holder.

 

(c)            
Promptly after receipt by an indemnified party under this Section 2.8 of notice of the commencement of any action (including any
governmental action) for which a party may be entitled to indemnification hereunder, such indemnified party will, if a claim in respect
thereof is to be made against any indemnifying party under this Section 2.8, give the indemnifying party notice of the commencement thereof.
The indemnifying party shall have the right to participate in such action and, to the extent the indemnifying party so desires, participate
jointly with any other indemnifying party to which notice has been given, and to assume the defense thereof with counsel mutually satisfactory
to the parties; provided, however, that an indemnified party (together with all other indemnified parties that may be represented without
conflict by one counsel) shall have the right to retain one separate counsel, with the fees and expenses to be paid by the indemnifying
party, if representation of such indemnified party by the counsel retained by the indemnifying party would be inappropriate due to actual
or potential differing interests between such indemnified party and any other party represented by such counsel in such action.

 

(d)            
To provide for just and equitable contribution to joint liability under the Securities Act in any case in which either: (i) any
party otherwise entitled to indemnification hereunder makes a claim for indemnification pursuant to this Section 2.8 but it is judicially
determined (by the entry of a final judgment or decree by a court of competent jurisdiction and the expiration of time to appeal or the
denial of the last right of appeal) that such indemnification may not be enforced in such case, notwithstanding the fact that this Section
2.8 provides for indemnification in such case, or (ii) contribution under the Securities Act may be required on the part of any party
hereto for which indemnification is provided under this Section 2.8, then, and in each such case, such parties will contribute to the
aggregate losses, claims, damages, liabilities, or expenses to which they may be subject (after contribution from others) in such proportion
as is appropriate to reflect the relative fault of each of the indemnifying party and the indemnified party in connection with the statements,
omissions, or other actions that resulted in such loss, claim, damage, liability, or expense, as well as to reflect any other relevant
equitable considerations. The relative fault of the indemnifying party and of the indemnified party shall be determined by reference
to, among other things, whether the untrue or allegedly untrue statement of a material fact, or the omission or alleged omission of a
material fact, relates to information supplied by the indemnifying party or by the indemnified party and the parties’ relative
intent, knowledge, access to information, and opportunity to correct or prevent such statement or omission; provided, however, that,
in any such case (x) no Holder will be required to contribute any amount in excess of the public offering price of all such Registrable
Securities offered and sold by such Holder pursuant to such registration statement, and (y) no Person guilty of fraudulent misrepresentation
(within the meaning of Section 11(f) of the Securities Act) will be entitled to contribution from any Person who was not guilty of such
fraudulent misrepresentation; and provided further that in no event shall a Holder’s liability pursuant to this Section 2.8(d),
when combined with the amounts paid or payable by such Holder pursuant to Section 2.8(b), exceed the proceeds from the offering received
by such Holder (net of any Selling Expenses paid by such Holder), except in the case of willful misconduct or fraud by such Holder.

 

 

    	 	12	 

     

    

 

(e)            
Unless otherwise superseded by an underwriting agreement entered into in connection with the underwritten public offering, the
obligations of the Company and Holders under this Section 2.8 
shall survive the completion of any offering of Registrable Securities in a registration under this Section 2, and otherwise shall
survive the termination of this Agreement.

 

2.9           
Reports Under Exchange Act. With a view to making available to the Holders the benefits of SEC Rule 144 and any other rule
or regulation of the SEC that may at any time permit a Holder to sell securities of the Company to the public without registration or
pursuant to a registration on Form S-3, the Company shall:

 

(a)            
make and keep available adequate current public information, as those terms are understood and defined in SEC Rule 144, at all
times after the effective date of the registration statement filed by the Company for the IPO;

 

(b)            
use commercially reasonable efforts to file with the SEC in a timely manner all reports and other documents required of the Company
under the Securities Act and the Exchange Act (at any time after the Company has become subject to such reporting requirements); and

 

(c)            
furnish to any Holder, so long as the Holder owns any Registrable Securities, forthwith upon request (i) to the extent accurate,
a written statement by the Company that it has complied with the reporting requirements of SEC Rule 144 (at any time after ninety (90)
days after the effective date of the registration statement filed by the Company for the IPO), the Securities Act, and the Exchange Act
(at any time after the Company has become subject to such reporting requirements), or that it qualifies as a registrant whose securities
may be resold pursuant to Form S-3 (at any time after the Company so qualifies); and (iii) such other information as may be reasonably
requested in availing any Holder of any rule or regulation of the SEC that permits the selling of any such securities without registration
(at any time after the Company has become subject to the reporting requirements under the Exchange Act) or pursuant to Form S-3 (at any
time after the Company so qualifies to use such form).

 

2.10        
Limitations on Subsequent Registration Rights. From and after the date of this Agreement, the Company shall not, without
the prior written consent of the Holders of twenty-five percent (25%) of the Registrable Securities then outstanding, enter into any agreement
with any holder or prospective holder of any securities of the Company that would (i) allow such holder or prospective holder to include
such securities in any registration unless, under the terms of such agreement, such holder or prospective holder may include such securities
in any such registration only to the extent that the inclusion of such securities will not reduce the number of the Registrable Securities
of the Holders that are included; or (ii) allow such holder or prospective holder to initiate a demand for registration of any securities
held by such holder or prospective holder; provided that this limitation shall not apply to Registrable Securities acquired by any additional
Investor that becomes a party to this Agreement in accordance with Section 6.9.

 

 

    	 	13	 

     

    

 

2.11        
“Market Stand-off” Agreement. Each Holder hereby agrees that it will not, without the prior written consent
of the managing underwriter, during the period commencing on the date of the final prospectus relating to the registration by the Company
for its own behalf of shares of its Common Stock or any other equity securities under the Securities Act on a registration statement
on Form S-1 or Form S-3, and ending on the date specified by the Company and the managing underwriter (such period not to exceed one
hundred eighty (180) days in the case of the IPO, or such other period as may be requested by the Company or an underwriter to accommodate
regulatory restrictions on (1) the publication or other distribution of research reports, and (2) analyst recommendations and opinions,
including, but not limited to, the restrictions contained in applicable FINRA rules, or any successor provisions or amendments thereto),
(i) lend; offer; pledge; sell; contract to sell; sell any option or contract to purchase; purchase any option or contract to sell; grant
any option, right, or warrant to purchase; or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or
any securities convertible into or exercisable or exchangeable (directly or indirectly) for Common Stock held immediately before the
effective date of the registration statement for such offering or (ii) enter into any swap or other arrangement that transfers to another,
in whole or in part, any of the economic consequences of ownership of such securities, whether any such transaction described in clause
(i) or (ii) above is to be settled by delivery of Common Stock or other securities, in cash, or otherwise. The foregoing provisions of
this Section 2.11 shall not apply to the sale of any shares to an underwriter pursuant to an underwriting agreement, or the transfer
of any shares to any trust for the direct or indirect benefit of the Holder or the immediate family of the Holder, provided that the
trustee of the trust agrees to be bound in writing by the restrictions set forth herein, and provided further that any such transfer
shall not involve a disposition for value, and shall be applicable to the Holders only if all officers and directors are subject to the
same restrictions and the Company uses commercially reasonable efforts to obtain a similar agreement from all stockholders individually
owning more than five percent (5%) of the Company’s outstanding Common Stock (after giving effect to conversion into Common Stock
of all outstanding Convertible Debentures. The underwriters in connection with such registration are intended third-party beneficiaries
of this Section 2.11 and shall have the right, power and authority to enforce the provisions hereof as though they were a party hereto.
Each Holder further agrees to execute such agreements as may be reasonably requested by the underwriters in connection with such registration
that are consistent with this Section 2.11 or that are necessary to give further effect thereto.

 

2.12        
Restrictions on Transfer.

 

(a)            
The Registrable Securities shall not be sold, pledged, or otherwise transferred, and the Company shall not recognize and shall
issue stop-transfer instructions to its transfer agent with respect to any such sale, pledge, or transfer, except upon the conditions
specified in this Agreement, which conditions are intended to ensure compliance with the provisions of the Securities Act. A transferring
Holder will cause any proposed purchaser, pledgee, or transferee of the Registrable Securities held by such Holder to agree to take and
hold such securities subject to the provisions and upon the conditions specified in this Agreement.

 

(b)            
Each certificate, instrument, or book entry representing (i) the Registrable Securities, and (ii) any other securities issued in
respect of the securities referenced in clauses (i), upon any stock split, stock dividend, recapitalization, merger, consolidation, or
similar event, shall (unless otherwise permitted by the provisions of Section 2.12(c)) be notated with a legend substantially in the following
form:

 

THE SECURITIES REPRESENTED HEREBY
HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933. SUCH SHARES MAY NOT BE SOLD, PLEDGED,
OR TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR A VALID EXEMPTION FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS OF
SAID ACT.

 

The Holders consent
to the Company making a notation in its records and giving instructions to any transfer agent of the Restricted Securities in order to
implement the restrictions on transfer set forth in this Section 2.12.

 

 

    	 	14	 

     

    

 

(c)            
The holder of such Restricted Securities, by acceptance of ownership thereof, agrees to comply in all respects with the provisions
of this Section 2. Before any proposed sale, pledge, or transfer of any Restricted Securities, unless there is in effect a registration
statement under the Securities Act covering the proposed transaction, the Holder thereof shall give notice to the Company of such Holder’s
intention to effect such sale, pledge, or transfer. Each such notice shall describe the manner and circumstances of the proposed sale,
pledge, or transfer in sufficient detail and, if reasonably requested by the Company, shall be accompanied at such Holder’s expense
by either (i) a written opinion of legal counsel who shall, and whose legal opinion shall, be reasonably satisfactory to the Company,
addressed to the Company, to the effect that the proposed transaction may be effected without registration under the Securities Act;
(ii) a “no action” letter from the SEC to the effect that the proposed sale, pledge, or transfer of such Restricted Securities
without registration will not result in a recommendation by the staff of the SEC that action be taken with respect thereto; or (iii)
any other evidence reasonably satisfactory to counsel to the Company to the effect that the proposed sale, pledge, or transfer of the
Restricted Securities may be effected without registration under the Securities Act, whereupon the Holder of such Restricted Securities
shall be entitled to sell, pledge, or transfer such Restricted Securities in accordance with the terms of the notice given by the Holder
to the Company. The Company will not require such a legal opinion or “no action” letter (x) in any transaction in compliance
with SEC Rule 144; or (y) in any transaction in which such Holder distributes Restricted Securities to an Affiliate of such Holder for
no consideration; provided that each transferee agrees in writing to be subject to the terms of this Section 2.12. Each certificate,
instrument, or book entry representing the Restricted Securities transferred as above provided shall be notated with, except if such
transfer is made pursuant to SEC Rule 144, the appropriate restrictive legend set forth in Section 2.12(b), except that such certificate
instrument, or book entry shall not be notated with such restrictive legend if, in the opinion of counsel for such Holder and the Company,
such legend is not required in order to establish compliance with any provisions of the Securities Act.

 

2.13        
Termination of Registration Rights. The right of any Holder to request registration or inclusion of Registrable Securities
in any registration pursuant to Sections 2.1 or 2.2 shall terminate upon the earliest to occur of:

 

(a)            
such time after consummation of the IPO as Rule 144 or another similar exemption under the Securities Act is available for the
sale of all of such Holder’s shares without limitation during a three- month period without registration;

 

(b)            
the tenth (10th) anniversary of the date of this Agreement.

 

3.              
Information and Observer Rights.

 

3.1           
Delivery of Financial Statements. The Company shall deliver to each Major Investor:

 

(a)            
as soon as practicable, but in any event within ninety (90) days after the end of each fiscal year of the Company (i) a balance
sheet as of the end of such year, (ii) statements of income and of cash flows for such year, and a comparison between (x) the actual amounts
as of and for such fiscal year and (y) the comparable amounts for the prior year and as included in the Budget (as defined in Section
3.1(d)) for such year, with an explanation of any material differences between such amounts and a Schedule As to the sources and
applications of funds for such year, and (iii) a statement of stockholders’ equity as of the end of such year, all such financial
statements audited and certified by independent public accountants of regionally recognized standing selected by the Company;

 

(b)            
as soon as practicable, but in any event within forty-five (45) days after the end of each of the first three (3) quarters of each
fiscal year of the Company, unaudited statements of income and cash flows for such fiscal quarter, and an unaudited balance sheet and
a statement of stockholders’ equity as of the end of such fiscal quarter, all prepared in accordance with GAAP (except that such
financial statements may (i) be subject to normal year-end audit adjustments; and (ii) not contain all notes thereto that may be required
in accordance with GAAP);

 

 

    	 	15	 

     

    

 

(c)            
as soon as practicable, but in any event within forty-five (45) days after the end of each of the first three (3) quarters of
each fiscal year of the Company, a statement showing the number of shares of each class and series of capital stock and securities convertible
into or exercisable for shares of capital stock outstanding at the end of the period, the Common Stock issuable upon conversion or exercise
of any outstanding securities convertible or exercisable for Common Stock and the exchange ratio or exercise price applicable thereto,
and the number of shares of issued stock options and stock options not yet issued but reserved for issuance, if any, all in sufficient
detail as to permit the Major Investors to calculate their respective percentage equity ownership in the Company, and certified by the
chief financial officer or chief executive officer of the Company as being true, complete, and correct;

 

(d)            
as soon as practicable, but in any event thirty (30) days before the end of each fiscal year, a budget and business plan for the
next fiscal year (collectively, the “Budget”), approved by the Board of Directors (including at least two (2) of the Lead
Investor Directors) and prepared on a monthly basis, including balance sheets, income statements, and statements of cash flow for such
months and, promptly after prepared, any other budgets or revised budgets prepared by the Company;

 

(e)            
with respect to the financial statements called for in Section 3.1(a), Section 3.1(b) and Section 3.13.1(c), an instrument executed
by the chief financial officer and chief executive officer of the Company certifying that such financial statements were prepared in accordance
with GAAP consistently applied with prior practice for earlier periods (except as otherwise set forth in Section 3.1(b) and Section 3.13.1(d))
and fairly present the financial condition of the Company and its results of operation for the periods specified therein; and

 

(f)             
such other information relating to the financial condition, business, prospects, or corporate affairs of the Company as any Major
Investor may from time to time reasonably request; provided, however, that the Company shall not be obligated under this Section 3.1 to
provide information (i) that the Company reasonably determines in good faith to be a trade secret or confidential information (unless
covered by an enforceable confidentiality agreement, in a form acceptable to the Company); or (ii) the disclosure of which would adversely
affect the attorney-client privilege between the Company and its counsel.

 

If, for any period, the Company has
any subsidiary whose accounts are consolidated with those of the Company, then in respect of such period the financial statements delivered
pursuant to the foregoing sections shall be the consolidated and consolidating financial statements of the Company and all such consolidated
subsidiaries. Notwithstanding anything else in this Section 3.1 to the contrary, the Company may cease providing the information set forth
in this Section 3.1 during the period starting with the date thirty (30) days before the Company’s good- faith estimate of the date
of filing of a registration statement if it reasonably concludes it must do so to comply with the SEC rules applicable to such registration
statement and related offering; provided that the Company’s covenants under this Section 3.1 shall be reinstated at such time as
the Company is no longer actively employing its commercially reasonable efforts to cause such registration statement to become effective.

 

3.2           
Inspection. The Company shall permit each Major Investor (provided that the Board of Directors has not reasonably determined
that such Major Investor is a competitor of the Company), at such Major Investor’s expense, to visit and inspect the Company’s
properties; examine its books of account and records; and discuss the Company’s affairs, finances, and accounts with its officers,
during normal business hours of the Company as may be reasonably requested by the Major Investor; provided, however, that the Company
shall not be obligated pursuant to this Section 3.2 to provide access to any information that it reasonably and in good faith considers
to be a trade secret or confidential information (unless covered by an enforceable confidentiality agreement, in form acceptable to the
Company) or the disclosure of which would adversely affect the attorney- client privilege between the Company and its counsel.

 

3.3           
Termination of Information. The covenants set forth in Section 3.1 and Section 3.2 shall terminate and be of no further force
or effect (i) immediately before the consummation of the IPO, or (ii) when the Company first becomes subject to the periodic reporting
requirements of Section 12(g) or 15(d) of the Exchange Act, whichever event occurs first.

 

 

    	 	16	 

     

    

 

3.4           
Confidentiality. Each Investor agrees that such Investor will keep confidential and will not disclose, divulge, or use for
any purpose (other than to monitor its investment in the Company) any confidential information obtained from the Company pursuant to the
terms of this Agreement (including notice of the Company’s intention to file a registration statement), unless such confidential
information (a) is known or becomes known to the public in general (other than as a result of a breach of this Section 3.4 by such Investor),
(b) is or has been independently developed or conceived by such Investor without use of the Company’s confidential information,
or (c) is or has been made known or disclosed to such Investor by a third party without a breach of any obligation of confidentiality
such third party may have to the Company; provided, however, that an Investor may disclose confidential information (i) to its attorneys,
accountants, consultants, and other professionals to the extent necessary to obtain their services in connection with monitoring its investment
in the Company; (ii) to any prospective purchaser of any Registrable Securities from such Investor, if such prospective purchaser agrees
to be bound by the provisions of this Section 3.4; (iii) to any Affiliate, partner, member, stockholder, or wholly owned subsidiary of
such Investor in the ordinary course of business, provided that such Investor informs such Person that such information is confidential
and directs such Person to maintain the confidentiality of such information; or (iv) as may otherwise be required by law, regulation,
rule, court order or subpoena, provided that such Investor promptly notifies the Company of such disclosure and takes reasonable steps
to minimize the extent of any such required disclosure.

 

4.              
Rights to Future Stock Issuances.

 

4.1           
Right of First Offer. Subject to the terms and conditions of this Section 4.1 and applicable securities laws, if the Company
proposes to offer or sell any New Securities, the Company shall first offer such New Securities to the Major Investors. Each Major Investor
shall be entitled to apportion the right of first offer hereby granted to it in such proportions as it deems appropriate, among (i) itself,
(ii) its Affiliates and (iii) its beneficial interest holders, such as limited partners, members or any other Person having “beneficial
ownership,” as such term is defined in Rule 13d-3 promulgated under the Exchange Act, of such Major Investor (“Investor
Beneficial Owners”); provided that each such Affiliate or Investor Beneficial Owner (x) is not a Competitor, unless such party’s
purchase of New Securities is otherwise consented to by the Board of Directors, (y) agrees to enter into this Agreement and each of the
Voting Agreement and Right of First Refusal and Co-Sale Agreement of even date herewith among the Company, the Investors and the other
parties named therein, as an “Investor” under each such agreement (provided that any Competitor shall not be entitled
to any rights as the Lead Investor under Sections 3.1,

3.2 
and 4.1 hereof), and (z) agrees to purchase at least such number of New Securities as are allocable hereunder to the Lead Investor.

 

(a)            
The Company shall give notice (the “Offer Notice”) to each Major Investor, stating (i) its bona fide intention
to offer such New Securities, (ii) the number of such New Securities to be offered, and (iii) the price and terms, if any, upon which
it proposes to offer such New Securities.

 

(b)            
By notification to the Company within twenty (20) days after the Offer Notice is given, each Major Investor may elect to purchase
or otherwise acquire, at the price and on the terms specified in the Offer Notice, up to that portion of such New Securities which equals
the proportion that the Common Stock then held by such Major Investor (including all shares of Common Stock then issuable (directly or
indirectly) upon conversion and/or exercise, as applicable, of the Convertible Debentures and Derivative Securities then held by such
Major Investor) bears to the total Common Stock of the Company then outstanding (assuming full conversion and/or exercise, as applicable,
of all Convertible Debentures and any other Derivative Securities then outstanding). At the expiration of such twenty (20) day period,
the Company shall promptly notify each Major Investor that elects to purchase or acquire all the shares available to it (each, a “Fully
Exercising Investor”) of any other Major Investor’s failure to do likewise. During the ten (10) day period commencing
after the Company has given such notice, each Fully Exercising Investor may, by giving notice to the Company, elect to purchase or acquire,
in addition to the number of shares specified above, up to that portion of the New Securities for which Major Investors were entitled
to subscribe but that were not subscribed for by the Major Investors which is equal to the proportion that the Common Stock issued and
held, or issuable (directly or indirectly) upon conversion and/or exercise, as applicable, of Convertible Debentures and any other Derivative
Securities then held, by such Fully Exercising Investor bears to the Common Stock issued and held, or issuable (directly or indirectly)
upon conversion and/or exercise, as applicable, of the Convertible Debentures and any other Derivative Securities then held, by all Fully
Exercising Investors who wish to purchase such unsubscribed shares. The closing of any sale pursuant to this Section 4.1(b) shall occur
within the later of ninety (90) days of the date that the Offer Notice is given and the date of initial sale of New Securities pursuant
to Section 4.1(c).

 

 

    	 	17	 

     

    

 

(c)            
If all New Securities referred to in the Offer Notice are not elected to be purchased or acquired as provided in Section 4.1(b),
the Company may, during the ninety (90)- day period following the expiration of the periods provided in Section 4.1(b), offer and sell
the remaining unsubscribed portion of such New Securities to any Person or Persons at a price not less than, and upon terms no more favorable
to the offeree than, those specified in the Offer Notice. If the Company does not enter into an agreement for the sale of the New Securities
within such period, or if such agreement is not consummated within thirty (30) days of the execution thereof, the right provided hereunder
shall be deemed to be revived and such New Securities shall not be offered unless first reoffered to the Major Investors in accordance
with this Section 4.1.

 

(d)            
The right of first offer in this Section 4.1 shall not be applicable to (i) Exempted Securities (as defined in the Amended Articles);
(ii) shares of Common Stock issued in the IPO; and (iii) the issuance of Convertible Debentures to Additional Purchasers pursuant to the
Purchase Agreement.

 

4.2 Termination.
The covenants set forth in Section 4.1 shall terminate and be of no further force or effect (i) immediately before the consummation of
the IPO, (ii) when the Company first becomes subject to the periodic reporting requirements of Section 12(g) or 15(d) of the Exchange
Act, whichever event occurs first.

 

5.              
Additional Covenants.

 

5.1           
Insurance. The Company shall obtain, within ninety (90) days of the date hereof, from financially sound and reputable insurers
Directors and Officers liability insurance and term “key-person” insurance on members of the Board of Directors and the officers,
each in an amount and on terms and conditions satisfactory to the Board of Directors, and will use commercially reasonable efforts to
cause such insurance policies to be maintained until such time as the Board of Directors determines that such insurance should be discontinued.
The key-person policy shall name the Company as loss payee, and neither policy shall be cancelable by the Company without prior approval
by the Board of Directors including at least two (2) of the Lead Investor Directors.

 

5.2           
Employee Agreements. The Company will cause (i) each Person now or hereafter employed by it or by any subsidiary (or engaged
by the Company or any subsidiary as a consultant/independent contractor) with access to confidential information and/or trade secrets
to enter into a nondisclosure and proprietary rights assignment agreement; and (ii) each Key Employee to enter into a one (1) year non-competition
and non- solicitation agreement, substantially in the form approved by the Board of Directors. In addition, the Company shall not amend,
modify, terminate, waive, or otherwise alter, in whole or in part, any of the above-referenced agreements or any restricted stock agreement
between the Company and any employee, without the approval of least two (2) of the Lead Investor Directors.

 

5.3           
Employee Stock. [RESERVED].

 

5.4           
Matters Requiring Investor Director Approval. So long as the Lead Investor is entitled to elect Lead Investor Directors, the
Company hereby covenants and agrees with each of the Investors that it shall not, without approval of the Board of Directors, which approval
must include the affirmative vote of at least two (2) 
of the Lead Investor Directors:

 

 

    	 	18	 

     

    

 

(a)            
make, or permit any subsidiary to make, any loan or advance to, or own any stock or other securities of, any subsidiary or other
corporation, partnership, or other entity unless it is wholly owned by the Company;

 

(b)            
make, or permit any subsidiary to make, any loan or advance to any Person, including, without limitation, any employee or director
of the Company or any subsidiary, except advances and similar expenditures in the ordinary course of business or under the terms of an
employee stock or option plan approved by the Board of Directors;

 

(c)            
guarantee, directly or indirectly, or permit any subsidiary to guarantee, directly or indirectly, any indebtedness except for trade
accounts of the Company or any subsidiary arising in the ordinary course of business;

 

(d)            
make any investment inconsistent with any investment policy approved by the

Board of Directors;

 

(e)            
incur any aggregate indebtedness in excess of $100,000.00 that is not already included in a Budget approved by the Board of Directors,
other than trade credit incurred in the ordinary course of business;

 

(f)             
[RESERVED];

 

(g)            
hire, terminate, or change the compensation of the executive officers, including approving any option grants or stock awards to
executive officers;

 

(h)            
change the principal business of the Company, enter new lines of business, or exit the current line of business;

 

(i)             
sell, assign, license, pledge, or encumber material technology or intellectual property, other than licenses granted in the ordinary
course of business; or

 

(j)             
enter into any corporate strategic relationship involving the payment, contribution, or assignment by the Company or to the Company
of money or assets greater than $100,000.00.

 

5.5           
Board Matters. Unless otherwise determined by the vote of a majority of the directors then in office, the Board of Directors
shall meet at least quarterly in accordance with an agreed-upon schedule. The Company shall reimburse the nonemployee directors for all
reasonable out-of-pocket travel expenses incurred (consistent with the Company’s travel policy) in connection with attending meetings
of the Board of Directors. The Company shall cause to be established, as soon as practicable after such request, and will maintain, an
audit and compensation committee, each of which shall consist solely of non-management directors. Each non-employee director shall be
entitled in such person’s discretion to be a member of any committee of the Board of Directors.

 

5.6                            
Successor Indemnification. If the Company or any of its successors or assignees consolidates with or merges into any other
Person and is not the continuing or surviving corporation or entity of such consolidation or merger, then to the extent necessary, proper
provision shall be made so that the successors and assignees of the Company assume the obligations of the Company with respect to indemnification
of members of the Board of Directors as in effect immediately before such transaction, whether such obligations are contained in the Company’s
Bylaws, the Certificate of Incorporation, or elsewhere, as the case may be.

 

    	 	19	 

     

    

 

5.7                            
Expenses of Counsel. In the event of a transaction which is a Sale of the Company, the reasonable fees and disbursements,
not to exceed $100,000.00 of one counsel for the Investors (“Investor Counsel”), in their capacities as stockholders,
shall be borne and paid by the Company. At the outset of considering a transaction which, if consummated would constitute a Sale of the
Company, the Company shall obtain the ability to share with the Investor Counsel (and such counsel's clients) and shall share the confidential
information (including, without limitation, the initial and all subsequent drafts of memoranda of understanding, letters of intent and
other transaction documents and related noncompete, employment, consulting and other compensation agreements and plans) pertaining to
and memorializing any of the transactions which, individually or when aggregated with others would constitute the Sale of the Company.
The Company shall be obligated to share (and cause the Company's counsel and investment bankers to share) such materials when distributed
to the Company's executives and/or any one or more of the other parties to such transaction(s). In the event that Investor Counsel deems
it appropriate, in its reasonable discretion, to enter into a joint defense agreement or other arrangement to enhance the ability of
the parties to protect their communications and other reviewed materials under the attorney client privilege, the Company shall, and
shall direct its counsel to, execute and deliver to Investor Counsel and its clients such an agreement in form and substance reasonably
acceptable to Investor Counsel. In the event that one or more of the other party or parties to such transactions require the clients
of Investor Counsel to enter into a confidentiality agreement and/or joint defense agreement in order to receive such information, then
the Company shall share whatever information can be shared without entry into such agreement and shall, at the same time, in good faith
work expeditiously to enable Investor Counsel and its clients to negotiate and enter into the appropriate agreement(s) without undue
burden to the clients of Investor Counsel.

 

5.8                            
Indemnification Matters. The Company hereby acknowledges that one (1) or more of the directors nominated to serve on the Board
of Directors by the Investors (each an “Investor Director”) may have certain rights to indemnification, advancement
of expenses and/or insurance provided by one or more of the Investors and certain of their Affiliates (collectively, the “Investor
Indemnitors”). The Company hereby agrees (a) that it is the indemnitor of first resort (i.e., its obligations to any
such Investor Director are primary and any obligation of the Investor Indemnitors to advance expenses or to provide indemnification for
the same expenses or liabilities incurred by such Investor Director are secondary), (b) that it shall be required to advance the full
amount of expenses incurred by such Investor Director and shall be liable for the full amount of all expenses, judgments, penalties,
fines and amounts paid in settlement by or on behalf of any such Investor Director to the extent legally permitted and as required by
the Company’s Certificate of Incorporation or Bylaws of the Company (or any agreement between the Company and such Investor Director),
without regard to any rights such Investor Director may have against the Investor Indemnitors, and, (c) that it irrevocably waives, relinquishes
and releases the Investor Indemnitors from any and all claims against the Investor Indemnitors for contribution, subrogation or any other
recovery of any kind in respect thereof. The Company further agrees that no advancement or payment by the Investor Indemnitors on behalf
of any such Investor Director with respect to any claim for which such Investor Director has sought indemnification from the Company
shall affect the foregoing and the Investor Indemnitors shall have a right of contribution and/or be subrogated to the extent of such
advancement or payment to all of the rights of recovery of such Investor Director against the Company. The Investor Directors and the
Investor Indemnitors are intended third-party beneficiaries of this Section 5.8 and shall have the right, power and authority to enforce
the provisions of this Section 5.8 as though they were a party to this Agreement.

 

5.9                            
Cybersecurity. The Company shall, within 180 days following the Closing (as defined in the Purchase Agreement), (a) identify
its sensitive data and information, and restrict access (through physical and electronic controls) to those individuals who have a need
to access it and (b) implement cybersecurity solution(s) (“Cybersecurity Solutions”) designed to protect its technology
and systems (including servers, laptops, desktops, cloud, containers, virtual environments and data centers) and all data contained in
such systems. The Company shall use commercially reasonable efforts to ensure that the Cybersecurity Solutions (x) are up-to-date and
include industry-standard protections (e.g., antivirus, endpoint detection and response and threat hunting), (y) to the extent determined
necessary by the Company or its Board of Directors, are backed by a breach prevention warranty from the vendor certifying the effectiveness
of such solutions, and (z) require the vendors to notify the Company of any security incidents posing a risk to the Company’s information
(regardless of whether information was actually compromised). The Company shall evaluate on a regular basis whether the Cybersecurity
Solutions should be updated to ensure continued effectiveness and industry-standard protections. The Company shall also educate its employees
about the proper use and storage of sensitive information, including regular training as determined reasonably necessary by the Company
or its Board of Directors.

 

 

    	 	20	 

     

    

 

5.10                         
Termination of Covenants. The covenants set forth in this Section 5, except for Sections 5.6, 5.7 and 5.8, shall terminate
and be of no further force or effect (i) immediately before the consummation of the IPO, (ii) when the Company first becomes subject to
the periodic reporting requirements of Section 12(g) or 15(d) of the Exchange Act, whichever event occurs first.

 

6.              
Miscellaneous.

 

6.1           
Successors and Assigns. The rights under this Agreement may be assigned (but only with all related obligations) by a Holder
to a transferee of Registrable Securities that (i) is an Affiliate of a Holder; (ii) is a Holder’s Immediate Family Member or trust
for the benefit of an individual Holder or one or more of such Holder’s Immediate Family Members; or (iii) after such transfer,
holds at least fifty percent (50%) of the Registrable Securities (subject to appropriate adjustment for stock splits, stock dividends,
combinations, and other recapitalizations); provided, however, that (x) the Company is, within a reasonable time after such transfer,
furnished with written notice of the name and address of such transferee and the Registrable Securities with respect to which such rights
are being transferred; and (y) such transferee agrees in a written instrument delivered to the Company to be bound by and subject to the
terms and conditions of this Agreement, including the provisions of Section 2.11. For the purposes of determining the number of shares
of Registrable Securities held by a transferee, the holdings of a transferee (1) that is an Affiliate or stockholder of a Holder; (2)
who is a Holder’s Immediate Family Member; or (3) that is a trust for the benefit of an individual Holder or such Holder’s
Immediate Family Member shall be aggregated together and with those of the transferring Holder; provided further that all transferees
who would not qualify individually for assignment of rights shall, as a condition to the applicable transfer, establish a single attorney-in-fact
for the purpose of exercising any rights, receiving notices, or taking any action under this Agreement. The terms and conditions of this
Agreement inure to the benefit of and are binding upon the respective successors and permitted assignees of the parties. Nothing in this
Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors and permitted
assignees any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided herein.

 

6.2           
Governing Law. This Agreement shall be governed by the internal law of the State of Delaware, without regard to conflict of
law principles that would result in the application of any law other than the law of the State of Delaware.

 

6.3           
Counterparts. This Agreement may be executed in two (2) or more counterparts, each of which shall be deemed an original, but
all of which together shall constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including
pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com) or other transmission
method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.

 

6.4           
Titles and Subtitles. The titles and subtitles used in this Agreement are for convenience only and are not to be considered
in construing or interpreting this Agreement.

 

6.5                            
Notices.

 

(a)            
All notices and other communications given or made pursuant to this Agreement shall be in writing and shall be deemed effectively
given upon the earlier of actual receipt or (i) personal delivery to the party to be notified; (ii) when sent, if sent by electronic
mail or facsimile during the recipient’s normal business hours, and if not sent during normal business hours, then on the recipient’s
next business day; (iii) five (5) days after having been sent by registered or certified mail, return receipt requested, postage prepaid;
or (iv) one (1) business day after the business day of deposit with a nationally recognized overnight courier, freight prepaid, specifying
next-day delivery, with written verification of receipt. All communications shall be sent to the respective parties at their addresses
as set forth on Schedule A, or to the principal office of the Company and to the attention of the Chief Executive Officer, in
the case of the Company, or to such email address, facsimile number, or address as subsequently modified by written notice given in accordance
with this Section 6.5.

 

 

    	 	21	 

     

    

 

(b)            
Each Investor and Key Holder consents to the delivery of any stockholder notice pursuant to, insofar as its consistent with Nevada
law applicable to stockholders of a Nevada corporation (and if not, then in accordance with such Nevada law), the Delaware General Corporation
Law (the “DGCL”), as amended or superseded from time to time, by electronic transmission pursuant to Section 232 of
the DGCL (or any successor thereto) at the electronic mail address or the facsimile number as on the books of the Company. To the extent
that any notice given by means of electronic transmission is returned or undeliverable for any reason, the foregoing consent shall be
deemed to have been revoked until a new or corrected electronic mail address has been provided, and such attempted Electronic Notice shall
be ineffective and deemed to not have been given. Each Investor and Key Holder agrees to promptly notify the Company of any change in
such stockholder’s electronic mail address, and that failure to do so shall not affect the foregoing.

 

6.6           
Amendments and Waivers. Any term of this Agreement may be amended, modified or terminated and the observance of any term of
this Agreement may be waived (either generally or in a particular instance, and either retroactively or prospectively) only with the written
consent of the Company and the holders of at least a majority of the Registrable Securities then outstanding, and the Lead Investor; provided
that the Company may in its sole discretion waive compliance with Section 2.12(c) (and the Company’s failure to object promptly
in writing after notification of a proposed assignment allegedly in violation of Section 2.12(c) shall be deemed to be a waiver); and
provided further that any provision hereof may be waived by any waiving party on such party’s own behalf, without the consent of
any other party. Notwithstanding the foregoing, (a) this Agreement may not be amended, modified or terminated and the observance of any
term hereof may not be waived with respect to any Investor without the written consent of such Investor, unless such amendment, modification,
termination, or waiver applies to all Investors in the same fashion (it being agreed that a waiver of the provisions of Section 4 with
respect to a particular transaction shall be deemed to apply to all Investors in the same fashion if such waiver does so by its terms,
notwithstanding the fact that certain Investors may nonetheless, by agreement with the Company, purchase securities in such transaction)
and (b) Sections 3.1 and 3.2, Section 4 and any other section of this Agreement applicable to the Major Investors (including this clause
(b) of this Section 6.6) may not be amended, modified, terminated or waived without the written consent of the holders of at least a majority
of the Registrable Securities then outstanding and held by the Major Investors. Notwithstanding the foregoing, Schedule A may be
amended by the Company from time to time to add transferees of any Registrable Securities in compliance with the terms of this Agreement
without the consent of the other parties; and Schedule A may also be amended by the Company after the date of this Agreement without
the consent of the other parties to add information regarding any additional Investor who becomes a party to this Agreement in accordance
with Section 6.9. The Company shall give prompt notice of any amendment, modification or termination hereof or waiver hereunder to any
party hereto that did not consent in writing to such amendment, modification, termination, or waiver. Any amendment, modification, termination,
or waiver effected in accordance with this Section 6.6 shall be binding on all parties hereto, regardless of whether any such party has
consented thereto. No waivers of or exceptions to any term, condition, or provision of this Agreement, in any one or more instances, shall
be deemed to be or construed as a further or continuing waiver of any such term, condition, or provision.

 

6.7           
Severability. In case any one or more of the provisions contained in this Agreement is for any reason held to be invalid, illegal
or unenforceable in any respect, such invalidity, illegality, or unenforceability shall not affect any other provision of this Agreement,
and such invalid, illegal, or unenforceable provision shall be reformed and construed so that it will be valid, legal, and enforceable
to the maximum extent permitted by law.

 

6.8           
Aggregation of Stock. All shares of Registrable Securities held or acquired by Affiliates shall be aggregated together for
the purpose of determining the availability of any rights under this Agreement and such Affiliated persons may apportion such rights as
among themselves in any manner they deem appropriate.

 

    	 	22	 

     

    

 

6.9           
Additional Investors. Notwithstanding anything to the contrary contained herein, if the Company issues additional Convertible
Debentures after the date hereof, whether pursuant to the Purchase Agreement or otherwise, any purchaser thereof may become a party to
this Agreement by executing and delivering an additional counterpart signature page to this Agreement, and thereafter shall be deemed
an “Investor” for all purposes hereunder. No action or consent by the Investors shall be required for such joinder to this
Agreement by such additional Investor, so long as such additional Investor has agreed in writing to be bound by all of the obligations
as an “Investor” hereunder.

 

6.10        
Entire Agreement. This Agreement (including its preamble, recitals, and any Schedules and Exhibits hereto) and the Purchase
Agreement, and the Amended Articles, and the other Transaction Agreements (as defined in the Purchase Agreement) constitute the full and
entire understanding and agreement between the parties with respect to the subject matter hereof, and any other written or oral agreement
relating to the subject matter hereof existing between the parties is expressly canceled.

 

6.11        
Dispute Resolution. The parties (a) hereby irrevocably and unconditionally submit to the jurisdiction of the state courts of
Miami Dade County, Florida, and to the jurisdiction of the United States District Courts for Miami-Dade County, Florida or the purpose
of any suit, action or other proceeding arising out of or based upon this Agreement, (b) agree not to commence any suit, action or other
proceeding arising out of or based upon this Agreement except in the state courts of Florida or the United States District Court for the
Southern District of Florida, and (c) hereby waive, and agree not to assert, by way of motion, as a defense, or otherwise, in any such
suit, action or proceeding, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property
is exempt or immune from attachment or execution, that the suit, action or proceeding is brought in an inconvenient forum, that the venue
of the suit, action or proceeding is improper or that this Agreement or the subject matter hereof may not be enforced in or by such court.
WAIVER OF JURY TRIAL: EACH PARTY HEREBY WAIVES ITS RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF
THIS AGREEMENT, THE OTHER TRANSACTION DOCUMENTS, THE SECURITIES OR THE SUBJECT MATTER HEREOF OR THEREOF. THE SCOPE OF THIS WAIVER IS INTENDED
TO BE ALL-ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT MATTER OF THIS TRANSACTION,
INCLUDING, WITHOUT LIMITATION, CONTRACT CLAIMS, TORT CLAIMS (INCLUDING NEGLIGENCE), BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON LAW AND
STATUTORY CLAIMS. THIS SECTION HAS BEEN FULLY DISCUSSED BY EACH OF THE PARTIES HERETO AND THESE PROVISIONS WILL NOT BE SUBJECT TO ANY
EXCEPTIONS. EACH PARTY HERETO HEREBY FURTHER WARRANTS AND REPRESENTS THAT SUCH PARTY HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL,
AND THAT SUCH PARTY KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL.

 

6.12        
Delays or Omissions. No delay or omission to exercise any right, power, or remedy accruing to any party under this Agreement,
upon any breach or default of any other party under this Agreement, shall impair any such right, power, or remedy of such nonbreaching
or non-defaulting party, nor shall it be construed to be a waiver of or acquiescence to any such breach or default, or to any similar
breach or default thereafter occurring, nor shall any waiver of any single breach or default be deemed a waiver of any other breach or
default theretofore or thereafter occurring. All remedies, whether under this Agreement or by law or otherwise afforded to any party,
shall be cumulative and not alternative.

 

[Remainder of Page Intentionally
Left Blank]

 

 

    	 	23	 

     

    

 

[Signature Page to Investors’
Rights Agreement]

 

IN WITNESS WHEREOF, the parties have executed this Agreement
as of the date first written above.

 

 

	 	COMPANY:

 

 

GAMEPLAN, INC., a Nevada corporation

 

 

By:________________________

Name: Eric Gravengaard

Title: CEO

 

 

KEY HOLDERS

 

 

By:________________________

Name: Eric Gravengaard

 

 

 

LEAD INVESTOR:

 

KGPLA Holdings, LLC

 

 

By: _________________________

Name: Mike Komaransky

Title: Authorized Person

 

 

 

 

    	 	24	 

     

    

 

SCHEDULE A

 

Investors

 

 

	Lead Investor Name	Lead Investor Address for Notice Purposes
	KGPLA Holdings, LLC, a

                                                                                Delaware limited liability company
	Attn: Mike Komaransky, Authorized Person

                                                                                (mkomaransky@gmail.com),

                                                                                850 New Burton Road, Suite 201, Dover, DE 19904

 

 

	Investor Name	Investor Address for Notice Purposes
	 	 

 

 

 

 

SCHEDULE B

 

Key Holders

 

 

	Key Holder Name	Key Holder Address for Notice Purposes
	Eric Gravengaard	211 W. Wacker Dr., Suite 1500a,

                                                                                Chicago, IL 60606, eric@athenabitcoin.com

 

 

 

 

    	 	25Exhibit 10.7

 

VOTING AGREEMENT

 

by and among, on the one hand,

 

GAMEPLAN, INC.,
a Nevada corporation

 

and

 

KEY HOLDERS AS
LISTED HEREIN

 

and

 

KGPLA HOLDINGS LLC, AS THE LEAD INVESTOR, AND
THE OTHER INVESTORS LISTED HEREIN

 

dated as of

 

January ___, 2020

 

 

 

 

    	 	1	 

     

    

 

TABLE OF CONTENTS

 

	1.	Voting Provisions Regarding the Board	1
	 	 	 
	 	1.1	Size of the Board	1
	 	1.2	Board Composition	1
	 	1.3	Failure to Designate a Board Member	2
	 	1.4	Removal of Board Members	2
	 	1.5	No Liability for Election of Recommended Directors	3
	 	1.6	Vote to Increase Authorized Common Stock	3
	 	 	 	 
	2.	Remedies	3
	 	 	 
	 	2.1	Covenants of the Company	3
	 	2.2	Specific Enforcement	3
	 	2.3	Remedies Cumulative	3
	 	 	 	 
	3.	“Bad Actor”	3
	 	 	 
	 	3.1	Definitions	3
	 	3.2 	Representations	4
	 	3.3 	Covenants	4
	 	 	 	 
	4.	Term	4
	 	 	 
	5.	Miscellaneous	4
	 	 	 
	 	5.1	Additional Parties	4
	 	5.2 	Transfers	 
	 	5.3	Successors and Assigns	5
	 	5.4	Governing Law	5
	 	5.5 	Counterparts	5
	 	5.6	Titles and Subtitles	5
	 	5.7	Notices	5
	 	5.8	Consent Required to Amend, Modify, Terminate or Waive	6
	 	5.9	Delays or Omissions	7
	 	5.10 	Severability	7
	 	5.11 	Entire Agreement	7
	 	5.12 	Share Certificate Legend	7
	 	5.13 	Stock Splits, Stock Dividends, Etc	7
	 	5.14 	Manner of Voting	7
	 	5.15 	Further Assurances	7
	 	5.16 	Dispute Resolution	8
	 	5.17 	Aggregation of Stock	8
	 	5.18 	Spousal Consent	8

 

 

 

 

    	 	2	 

     

    

 

VOTING AGREEMENT

 

THIS VOTING AGREEMENT (this
“Agreement”), is made as of the January ___, 2020, by and among GamePlan, Inc., a Nevada corporation (the “Company”),
the Lead Investor and each of the investors listed on Schedule A, each of which is referred to in this Agreement as an “Investor”,
and each of the stockholders listed on Schedule B, each of whom is referred to herein as a “Key Holder”, and
any Additional Investor (as defined in that certain Securities Purchase Agreement dated of even date herewith (the “Purchase
Agreement”)) that becomes a party to this Agreement in accordance with its terms. Capitalized terms used but not otherwise defined
herein shall have the meanings set forth in the Purchase Agreement. For purposes of this Agreement, Lead Investor, any Investor that is
made a party, Key Holders and the holders of common stock of the Company shall be referred to individually as a “Stockholder”
and, collectively, as the “Stockholders”.

 

RECITALS

 

A.             
Concurrently with the execution of this Agreement, the Company and the Investors are entering into a Securities Purchase Agreement
(the “Purchase Agreement”) providing for the sale of Convertible Debentures, and in connection with that agreement
the parties desire to provide the Investors with the right, among other rights, to designate the election of certain members of the board
of directors of the Company (the “Board”) in accordance with the terms of this Agreement.

 

B.              
The Amended and Restated Articles of Incorporation of the Company (the “Amended Articles”) provides that the
Lead Investor under the Purchase Agreement, exclusively and as a separate class on an as-converted basis, shall be entitled to elect three
(3) out of five (5) directors of the Company (the “Lead Investor Directors”) and the Key Holders of record of the shares
of common stock, $0.001 par value per share, of the Company (“Common Stock”), exclusively and as a separate class,
shall be entitled to elect two (2) of five (5) directors of the Company for so long as such Key Holders maintain a certain amount of such
shares pursuant to this Agreement.

 

C.              
The parties also desire to enter into this Agreement to set forth their agreements and understandings with respect to how shares
of the capital stock of the Company and Convertible Debentures voted on an as-converted basis held by them will be voted on, or tendered
in connection with, an acquisition of the Company, or an increase in the number of shares of Common Stock required to provide for the
conversion of the Convertible Debentures or any other convertible securities of the Company.

 

NOW, THEREFORE, the parties agree as follows:

 

1.       Voting
Provisions Regarding the Board.

 

1.1       Size
of the Board. Each Stockholder agrees to vote, or cause to be voted, all Shares (as defined below) owned by such Stockholder, or
over which such Stockholder has voting control, from time to time and at all times, in whatever manner as shall be necessary to ensure
that the size of the Board shall be set and remain at five (5) directors and may be increased only with the written consent of the Lead
Investor (voting as a single separate class and on an as-converted to Common Stock basis). For purposes of this Agreement, the term “Shares”
shall mean and include any securities of the Company that the holders of which are entitled to vote for members of the Board, including
without limitation, all shares of Common Stock and the Convertible Debentures on an as-converted basis in Common Stock, by whatever name
called, now owned or subsequently acquired by a Stockholder, however acquired, whether through stock splits, stock dividends, reclassifications,
recapitalizations, similar events or otherwise.

 

1.2       Board
Composition. Each Stockholder agrees to vote, or cause to be voted, all Shares owned by such Stockholder, or over which such Stockholder
has voting control, from time to time and at all times, in whatever manner as shall be necessary to ensure that at each annual or special
meeting of stockholders at which an election of directors is held or pursuant to any written consent of the stockholders, subject to Section
4, the following persons shall be elected to the Board:

 

 

 

    	 	3	 

     

    

 

(a)             
Three (3) persons designated from time to time by the Lead Investor, for so long as such Stockholder and its Affiliates (as defined
below) continue to own any “Lead Investor Common Stock” as defined in the Amended Articles (i.e.,
a total of 1,521,141,192 shares of common stock), which number is subject to appropriate adjustment for any stock splits, stock dividends,
combinations, recapitalizations and the like), which individuals shall be named as of the Closing pursuant to the Purchase Agreement,
and, for clarification any shares of Lead Investor Common Stock resold by the Lead Investor to any other Person that is not an Affiliate
of Lead Investor shall cease to become Lead Investor Common Stock for purposes hereof;

 

(b)            
Subject to Section 1.2(c), for so long as the Key Holders who are then providing services to the Company as officers, employees
or consultants hold at least an amount of shares designated as “Key Holder Common Stock” as defined in the Amended Articles
(i.e., a total of 868,960,471 shares of common stock) representing ten percent (10%) of the
Company’s total issued and outstanding shares (subject to appropriate adjustment for any stock splits, stock dividends, combinations,
recapitalizations and the like), two (2) individuals designated from time to time by the holders of a majority of the shares of Common
Stock held by the Key Holders, which individuals shall be named as of the Closing pursuant to the Purchase Agreement, and, for clarification
any shares of Key Holder Common Stock resold by a Key Holder to any other Person that is not an Affiliate of such Key Holder shall cease
to become Key Holder Common Stock for purposes hereof;

 

(c)             
One (1) of the Key Holders’ individual designees to the Board pursuant to this Section 1.2(c), shall be the then-serving
Chief Executive Officer of the Company (The “CEO Director”, which, as of the date hereof, is Eric Gravengaard for
so long as he serves as Chief Executive Officer of the Company), provided that, if for any reason the then-serving Chief Executive Officer
shall cease to serve as the Chief Executive Officer of the Company, each of the Key Holders shall promptly vote their respective Shares:
(i) to remove such former Chief Executive Officer of the Company from the Board if such person has not resigned as a member of the Board;
and (ii) to elect such person’s replacement as Chief Executive Officer of the Company as the new CEO Director; and

 

To the extent that any of clauses (a) through
(c) above shall not be applicable, any member of the Board who would otherwise have been designated in accordance with the terms thereof
shall instead be voted upon by all the stockholders of the Company entitled to vote thereon in accordance with, and pursuant to, the Amended
Articles.

 

For purposes of this Agreement,
an individual, firm, corporation, partnership, association, limited liability company, trust or any other entity (collectively, a “Person”)
shall be deemed an “Affiliate” of another Person who, directly or indirectly, controls, is controlled by or is under
common control with such Person, including, without limitation, any general partner, managing member, officer, director or trustee of
such Person, or any venture capital fund or registered investment company now or hereafter existing that is controlled by one or more
general partners, managing members or investment advisers of, or shares the same management company or investment adviser with, such
Person.

 

1.3       Failure to Designate a Board Member. In
the absence of any designation from the Persons or groups with the right to designate a director as specified above, the director
previously designated by them and then serving shall be reelected if still eligible and willing to serve as provided herein and
otherwise, such Board seat shall remain vacant.

 

1.4       Removal of Board Members. Each Stockholder also
agrees to vote, or cause to be voted, all Shares owned by such Stockholder, or over which such Stockholder has voting control, from time
to time and at all times, in whatever manner as shall be necessary to ensure that:

 

(a)       no
director elected pursuant to Sections 1.2 or Section 1.3 of this Agreement may be removed from office other than for cause unless (i)
such removal is directed or approved by the affirmative vote of the Person(s) entitled under Section 1.2 to designate that director; or
(ii) the Person(s) originally entitled to designate or approve such director or occupy such Board seat pursuant to Section 1.2 is no longer
so entitled to designate or approve such director or occupy such Board seat;

 

 

    	 	4	 

     

    

 

(b)            
any vacancies created by the resignation, removal or death of a director elected pursuant to Sections 1.2 or Section 1.3 shall
be filled pursuant to the provisions of this Section 1; and

 

(c)             
upon the request of any party entitled to designate a director as provided in Section 1.2(a) or Section 1.2(b) to remove such director,
such director shall be removed.

 

All Stockholders agree to execute any written
consents required to perform the obligations of this Section 1, and the Company agrees at the request of any Person or group entitled
to designate directors to call a special meeting of stockholders for the purpose of electing directors.

 

1.5       No
Liability for Election of Recommended Directors. No Stockholder, nor any Affiliate of any Stockholder, shall have any liability as
a result of designating a person for election as a director for any act or omission by such designated person in his or her capacity
as a director of the Company, nor shall any Stockholder have any liability as a result of voting for any such designee in accordance
with the provisions of this Agreement.

 

1.6       Vote
to Increase Authorized Common Stock. Each Stockholder agrees to
vote or cause to be voted all Shares owned by such Stockholder, or over which such Stockholder has voting control, from time to
time and at all times, in whatever manner as shall be necessary to increase the number of authorized shares of Common Stock from time
to time to ensure that there will be sufficient shares of Common Stock available for conversion of all Convertible Debentures outstanding
at any given time.

 

2.             
Remedies.

 

2.1       Covenants of the Company. The Company agrees
to use its best efforts, within the requirements of applicable law, to ensure that the rights granted under this Agreement are effective
and that the parties enjoy the benefits of this Agreement. Such actions include, without limitation, the use of the Company’s best
efforts to cause the nomination and election of the directors as provided in this Agreement.

 

2.2       Specific Enforcement. Each party acknowledges
and agrees that each party hereto will be irreparably damaged in the event any of the provisions of this Agreement are not performed
by the parties in accordance with their specific terms or are otherwise breached. Accordingly, it is agreed that each of the Company
and the Stockholders shall be entitled to an injunction to prevent breaches of this Agreement, and to specific enforcement of this Agreement
and its terms and provisions in any action instituted in any court of the United States or any state having subject matter jurisdiction.

 

2.3       Remedies Cumulative. All remedies, either
under this Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative.

 

3.             
“Bad Actor” Matters.

 

3.1       Definitions. For purposes of this Agreement:

 

(a)             
“Company Covered Person ”means, with respect to the Company as an “issuer” for purposes of Rule
506 promulgated under the Securities Act, any Person listed in the first paragraph of Rule 506(d)(1).

 

(b)            
“Disqualified Designee ”means any director designee to whom any Disqualification Event is applicable, except
for a Disqualification Event as to which Rule 506(d)(2)(ii) or (iii) or (d)(3) is applicable.

 

(c)             
“Disqualification Event ”means a “bad actor” disqualifying event described in Rule 506(d)(1)(i)-(viii)
promulgated under the Securities Act.

 

 

 

 

    	 	5	 

     

    

 

(d)            
“Rule 506(d) Related Party ”means, with respect to any Person, any other Person that is a beneficial owner of
such first Person’s securities for purposes of Rule 506(d) under the Securities Act.

 

(e)             
“Securities Act ”means the Securities Act of 1933, as amended.

 

3.2       Representations.

 

(a)             
Each Person with the right to designate or participate in the designation of a director pursuant to this Agreement hereby represents
that (i) such Person has exercised reasonable care to determine whether any Disqualification Event is applicable to such Person, any director
designee designated by such Person pursuant to Purchase Agreement or any of such Person’s Rule 506(d) Related Parties, except, if
applicable, for a Disqualification Event as to which Rule 506(d)(2)(ii) or (iii) or (d)(3) is applicable and (ii) no Disqualification
Event is applicable to such Person, any Board member designated by such Person pursuant to the Purchase Agreement or any of such Person’s
Rule 506(d) Related Parties, except, if applicable, for a Disqualification Event as to which Rule 506(d)(2)(ii) or (iii) or (d)(3) is
applicable. Notwithstanding anything to the contrary in this Agreement, each Investor makes no representation regarding any Person that
may be deemed to be a beneficial owner of the Company’s voting equity securities held by such Investor solely by virtue of that
Person being or becoming a party to (x) this Agreement, as may be subsequently amended, or (y) any other contract or written agreement
to which the Company and such Investor are parties regarding (1) the voting power, which includes the power to vote or to direct the voting
of, such security; and/or (2) the investment power, which includes the power to dispose, or to direct the disposition of, such security.

 

(b)            
The Company hereby represents and warrants to the Investors that no Disqualification Event is applicable to the Company or, to
the Company’s knowledge, any Company Covered Person, except for a Disqualification Event as to which Rule 506(d)(2)(ii–iv)
or (d)(3) is applicable.

 

3.3       Covenants. Each Person with the right
to designate or participate in the designation of a director pursuant to this Agreement covenants and agrees (i) not to designate or
participate in the designation of any director designee who, to such Person’s knowledge, is a Disqualified Designee, (ii) to
exercise reasonable care to determine whether any director designee designated by such person is a Disqualified Designee, (iii) that
in the event such Person becomes aware that any individual previously designated by any such Person is or has become a Disqualified
Designee, such Person shall as promptly as practicable take such actions as are necessary to remove such Disqualified Designee from
the Board and designate a replacement designee who is not a Disqualified Designee, and (iv) to notify the Company promptly in
writing in the event a Disqualification Event becomes applicable to such Person or any of its Rule 506(d) Related Parties, or, to
such Person’s knowledge, to such Person’s initial designee named in Section 1, except, if applicable, for a
Disqualification Event as to which Rule 506(d)(2)(ii) or (iii) or (d)(3) is applicable.

 

4.             
Term. This Agreement shall be effective as of the date hereof and shall continue in effect until and shall terminate
upon the earliest to occur of: (a) the consummation of the Company’s first underwritten public offering of its Common Stock on the
NYSE or NASDAQ (other than a registration statement relating either to the sale of securities to employees of the Company pursuant to
its stock option, stock purchase or similar plan or an SEC Rule 145 transaction or registration on other than a first tier U.S. or Canadian
exchange); and (b) termination of this Agreement in accordance with Section 5.8.

 

5.             
Miscellaneous.

 

5.1       Additional
Parties.

 

(a)       Notwithstanding
anything to the contrary contained herein, if the Company issues additional Convertible Debentures after the date hereof, as a condition
to the issuance of such shares the Company shall require that any purchaser of such shares become a party to this Agreement by executing
and delivering (i) the Adoption Agreement attached to this Agreement as Exhibit A, or (ii) a counterpart signature page hereto
agreeing to be bound by and subject to the terms of this Agreement as an Investor and Stockholder hereunder. In either event, each such
person shall thereafter be deemed an Investor and Stockholder for all purposes under this Agreement.

 

 

 

 

 

 

    	 	6	 

     

    

 

(b)       In
the event that after the date of this Agreement, the Company enters into an agreement with any Person to issue shares of capital stock
to such Person, following which such Person shall hold Shares constituting one percent (1%) or more of the then outstanding capital stock
of the Company (treating for this purpose all shares of Common Stock issuable upon exercise of or conversion of outstanding options, warrants
or convertible securities, as if exercised and/or converted or exchanged), then, the Company shall cause such Person, as a condition precedent
to entering into such agreement, to become a party to this Agreement by executing an Adoption Agreement in the form attached hereto as
Exhibit A, agreeing to be bound by and subject to the terms of this Agreement as a Stockholder and thereafter such person shall
be deemed a Stockholder for all purposes under this Agreement.

 

5.2       Transfers.
Each transferee or assignee of any Shares subject to this Agreement shall continue to be subject to the terms hereof, and, as a condition
precedent to the Company’s recognition of such transfer, each transferee or assignee shall agree in writing to be subject to each
of the terms of this Agreement by executing and delivering an Adoption Agreement substantially in the form attached hereto as Exhibit
A. Upon the execution and delivery of an Adoption Agreement by any transferee, such transferee shall be deemed to be a party hereto
as if such transferee were the transferor and such transferee’s signature appeared on the signature pages of this Agreement and
shall be deemed to be an Investor and Stockholder, or Key Holder and Stockholder, as applicable. The Company shall not permit the transfer
of the Shares subject to this Agreement on its books or issue a new certificate representing any such Shares unless and until such transferee
shall have complied with the terms of this Section 5.2. Each certificate instrument, or book entry representing the Shares subject to
this Agreement if issued on or after the date of this Agreement shall be notated by the Company with the legend set forth in Section
5.12.

 

5.3       Successors and Assigns. The terms and conditions
of this Agreement shall inure to the benefit of and be binding upon the respective successors and assigns of the parties. Nothing in
this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors
and assigns any rights, remedies, obligations, or liabilities under or by reason of this Agreement, except as expressly provided in this
Agreement.

 

5.4       Governing Law. This Agreement shall be governed
by the internal law of the State of Delaware, without regard to conflict of law principles that would result in the application of any
law other than the law of the State of Delaware.

 

5.5       Counterparts. This Agreement may be executed
in two (2) or more counterparts, each of  which shall be deemed an original, but all of which together shall constitute one and
the same instrument. Counterparts may be delivered via facsimile, electronic mail (including pdf or any electronic signature complying
with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com)
or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and
effective for all purposes.

 

5.6       Titles and Subtitles. The titles and subtitles
used in this Agreement are used for convenience only and are not to be considered in construing or interpreting this Agreement.

 

5.7       Notices.

 

(a)       All
notices and other communications given or made pursuant to this Agreement shall be in writing and shall be deemed effectively given upon
the earlier of actual receipt or (a) personal delivery to the party to be notified, (b) when sent, if sent by electronic mail or facsimile
during normal business hours of the recipient, and if not sent during normal business hours, then on the recipient’s next business
day, (c) five (5) days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one (1)
business day after the business day of deposit with a nationally recognized overnight courier, freight prepaid,

 

 

 

 

    	 	7	 

     

    

 

specifying next business day delivery, with
written verification of receipt. All communications shall be sent to the respective parties at their address as set forth on Schedule
A or Schedule B, or to such email address, facsimile number or address as subsequently modified by written notice given in
accordance with this Section 5.7.

 

(b)       Each
Investor and Key Holder consents to the delivery of any stockholder notice pursuant to, insofar as it is consistent with Nevada law applicable
to stockholders of a Nevada corporation (and if not, then in accordance with the Nevada Business Corporation Act), the Delaware General
Corporation Law (the “DGCL”), as amended or superseded from time to time, by electronic transmission pursuant to Section 232
of the DGCL (or any successor thereto) at the electronic mail address or the facsimile number set forth below such Investor’s or
Key Holder’s name on the Schedules hereto, as updated from time to time by notice to the Company, or as on the books of the Company.
To the extent that any notice given by means of electronic transmission is returned or undeliverable for any reason, the foregoing consent
shall be deemed to have been revoked until a new or corrected electronic mail address has been provided, and such attempted Electronic
Notice shall be ineffective and deemed to not have been given. Each Investor and Key Holder agrees to promptly notify the Company of any
change in its electronic mail address, and that failure to do so shall not affect the foregoing.

 

5.8       Consent
Required to Amend, Modify, Terminate or Waive. This Agreement may be amended, modified or terminated (other than pursuant to Section
3.1) and the observance of any term hereof may be waived (either generally or in a particular instance and either retroactively or prospectively)
only by a written instrument executed by (a) the Company; (b) the Key Holders of the Shares then held by the Key Holders who are then
providing services to the Company as officers, employees or consultants; and (c) the Lead Investor. Notwithstanding the foregoing:

 

(a)             
this Agreement may not be amended, modified or terminated and the observance of any term of this Agreement may not be waived with
respect to any Investor or Key Holder without the written consent of such Investor or Key Holder unless such amendment, modification,
termination or waiver applies to all Investors or Key Holders, as the case may be, in the same fashion;

 

(b)            
the provisions of Section 1.2(a) and this Section 5.8(b) may not be amended, modified, terminated or waived without the written
consent of the Lead Investor;

 

(c)             
the provisions of Section 1.2(b) and this Section 5.8(c) may not be amended, modified, terminated or waived without the written
consent of the Key Holders who are at such time providing services to the Company as an officer, employee or consultant;

 

(d)            
the consent of the Key Holders shall not be required for any amendment, modification, termination or waiver if such amendment,
modification, termination, or waiver either (A) is not directly applicable to the rights of the Key Holders hereunder; or (B) does not
adversely affect the rights of the Key Holders in a manner that is different than the effect on the rights of the other parties hereto;

 

(e)             
Schedule A may be amended by the Company from time to time in accordance with Section 1.3 of the Purchase Agreement
to add information regarding additional Investors (as defined in the Purchase Agreement) without the consent of the other parties hereto;
and

 

(f)             
any provision hereof may be waived by the waiving party on such party’s own behalf, without the consent of any other party.

 

The Company shall give prompt written notice
of any amendment, modification, termination, or waiver hereunder to any party that did not consent in writing thereto. Any amendment,
modification, termination, or waiver effected in accordance with this Section 5.8 shall be binding on each party and all of such party’s
successors and permitted assigns, whether or not any such party, successor or assignee entered into or approved such amendment, modification,
termination or waiver. For purposes of this Section 5.8, the requirement of a written instrument may be satisfied in the form of an action
by written consent of the Stockholders circulated by the Company and executed

 

 

 

 

    	 	8	 

     

    

 

by the Stockholder parties specified,
whether or not such action by written consent makes explicit reference to the terms of this Agreement.

 

5.9       Delays
or Omissions. No delay or omission to exercise any right, power or remedy accruing to any party under this Agreement, upon any breach
or default of any other party under this Agreement, shall impair any such right, power or remedy of such non-breaching or non-defaulting
party nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein, or of or in any similar breach
or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default
previously or thereafter occurring. Any waiver, permit, consent or approval of any kind or character on the part of any party of any
breach or default under this Agreement, or any waiver on the part of any party of any provisions or conditions of this Agreement, must
be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement
or by law or otherwise afforded to any party, shall be cumulative and not alternative.

 

5.10        Severability.
The invalidity or unenforceability of any provision hereof shall in no way affect the validity or enforceability of any other provision.

 

5.11       Entire Agreement.
This Agreement (including its preamble, recitals, and any Schedules and Exhibits hereto), and the Purchase Agreement, and the Amended
Articles, and the other Transaction Agreements (as defined in the Purchase Agreement) constitute the full and entire understanding and
agreement between the parties with respect to the subject matter hereof, and any other written or oral agreement relating to the subject
matter hereof existing between the parties is expressly canceled.

 

5.12       Share Certificate
Legend. Each certificate, instrument, or book entry representing any Shares issued after the date hereof shall be notated by the Company
with a legend reading substantially as follows:

 

“THE SHARES REPRESENTED HEREBY ARE SUBJECT
TO A VOTING AGREEMENT, AS MAY BE AMENDED FROM TIME TO TIME, (A COPY OF WHICH MAY BE OBTAINED UPON WRITTEN REQUEST FROM THE COMPANY), AND
BY ACCEPTING ANY INTEREST IN SUCH SHARES THE PERSON ACCEPTING SUCH INTEREST SHALL BE DEEMED TO AGREE TO AND SHALL BECOME BOUND BY ALL
THE PROVISIONS OF THAT VOTING AGREEMENT, INCLUDING CERTAIN RESTRICTIONS ON TRANSFER AND OWNERSHIP SET FORTH THEREIN.”

 

The Company, by its execution of this
Agreement, agrees that it will cause the certificates instruments, or book entry evidencing the Shares issued after the date hereof to
be notated with the legend required by this Section 5.12 of this Agreement, and it shall supply, free of charge, a copy of this Agreement
to any holder of such Shares upon written request from such holder to the Company at its principal office. The parties to this Agreement
do hereby agree that the failure to cause the certificates, instruments, or book entry evidencing the Shares to be notated with the legend
required by this Section 5.12 herein and/or the failure of the Company to supply, free of charge, a copy of this Agreement as provided
hereunder shall not affect the validity or enforcement of this Agreement.

 

5.13       Stock Splits,
Stock Dividends, Etc. In the event of any issuance of Shares or the voting securities of the Company hereafter to any of the Stockholders
(including, without limitation, in connection with any stock split, stock dividend, recapitalization, reorganization, or the like), such
Shares shall become subject to this Agreement and shall be notated with the legend set forth in Section 5.12.

 

5.14       Manner of
Voting. The voting of Shares pursuant to this Agreement may be effectuated in person, by proxy, by written consent or in any other
manner permitted by applicable law. For the avoidance of doubt, voting of the Shares pursuant to the Agreement need not make explicit
reference to the terms of this Agreement.

 

5.15 Further Assurances.
At any time or from time to time after the date hereof, the parties agree to cooperate with each other, and at the request of any other
party, to execute and deliver any further instruments or documents and to take all such
further action as the other party may reasonably request in order to carry out the intent of the parties hereunder.

 

    	 	9	 

     

    

 

5.16       Dispute Resolution.
The parties (a) hereby irrevocably and unconditionally submit to the jurisdiction of the state courts of Miami-Dade County, Florida, and
to the jurisdiction of the United States District Courts for the Southern District of Florida or the purpose of any suit, action or other
proceeding arising out of or based upon this Agreement, (b) agree not to commence any suit, action or other proceeding arising out of
or based upon this Agreement except in the state courts of Florida or the United States District Court for the Southern District of Florida,
and (c) hereby waive, and agree not to assert, by way of motion, as a defense, or otherwise, in any such suit, action or proceeding, any
claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment
or execution, that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding
is improper or that this Agreement or the subject matter hereof may not be enforced in or by such court. WAIVER OF JURY TRIAL: EACH PARTY
HEREBY WAIVES ITS RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS AGREEMENT, THE OTHER TRANSACTION
DOCUMENTS, THE SECURITIES OR THE SUBJECT MATTER HEREOF OR THEREOF. THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL-ENCOMPASSING OF ANY
AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT MATTER OF THIS TRANSACTION, INCLUDING, WITHOUT LIMITATION,
CONTRACT CLAIMS, TORT CLAIMS (INCLUDING NEGLIGENCE), BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS. THIS SECTION
HAS BEEN FULLY DISCUSSED BY EACH OF THE PARTIES HERETO AND THESE PROVISIONS WILL NOT BE SUBJECT TO ANY EXCEPTIONS. EACH PARTY HERETO HEREBY
FURTHER WARRANTS AND REPRESENTS THAT SUCH PARTY HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL, AND THAT SUCH PARTY KNOWINGLY AND VOLUNTARILY
WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL.

 

5.17       Aggregation of Stock.
All Shares held or acquired by a Stockholder and/or its Affiliates shall be aggregated together for the purpose of determining the availability
of any rights under this Agreement, and such Affiliated persons may apportion such rights as among themselves in any manner they deem
appropriate.

 

5.18       Spousal Consent.
If any individual Stockholder is married on the date of this Agreement, such Stockholder’s spouse shall execute and deliver to the
Company a consent of spouse in the form of 0 hereto (“Consent of Spouse”), effective on the date hereof. Notwithstanding
the execution and delivery thereof, such consent shall not be deemed to confer or convey to the spouse any rights in such Stockholder’s
Shares that do not otherwise exist by operation of law or the agreement of the parties. If any individual Stockholder should marry or
remarry subsequent to the date of this Agreement, such Stockholder shall within thirty (30) days thereafter obtain his/her new spouse’s
acknowledgement of and consent to the existence and binding effect of all restrictions contained in this Agreement by causing such spouse
to execute and deliver a Consent of Spouse acknowledging the restrictions and obligations contained in this Agreement and agreeing and
consenting to the same.

 

[Signature Page Follows]

 

 

 

    	 	10	 

     

    

 

 

EXHIBIT I TO SECURITIES PURCHASE AGREEMENT

 

[Signature Page to Voting Agreement]

 

IN WITNESS WHEREOF, the parties have executed this Voting Agreement
as of the date first written above.

 

 

	 	COMPANY:

 

GAMEPLAN, INC., a Nevada corporation

 

By:_________________

Name: Eric Gravengaard

Title: CEO

 

KEY HOLDERS

 

By:_________________

Name: Eric Gravengaard

 

LEAD INVESTOR:

 

KGPLA Holdings, LLC

 

By:_________________

Name: Mike Komaransky

Title: Authorized Person

 

 

 

    	 	11	 

     

    

 

SCHEDULE A

 

Investors

 

	Lead Investor Name	Lead Investor Address for Notice Purposes
	KGPLA Holdings, LLC, a Delaware limited liability company	
    Attn: Mike Komaransky, Authorized Person

(mkomaransky@gmail.com), 850 New Burton Road, Suite 201, Dover, DE 19904

     

	Investor Name	Investor Address for Notice Purposes	 
	 	 	 	 	 

 

 

SCHEDULE B

 

 Key Holders

 

	Key Holder Name	Key Holder Address for Notice Purposes
	Eric Gravengaard	211 W. Wacker Dr., Suite 1500a, Chicago, IL 60606, 

eric@athenabitcoin.com

 

 

 

 

 

 

 

 

    	 	12	 

     

    

  

EXHIBIT A

 

ADOPTION AGREEMENT

 

This
Adoption Agreement (“Adoption Agreement”) is executed on__________, 20__, by the undersigned (the “Holder”)
pursuant to the terms of that certain Voting Agreement dated as of _____ __, 20___ (the “Agreement”), by and among
GamePlan, Inc., a Nevada corporation (the “Company”) and certain of its Stockholders, as such Agreement may be amended or
amended and restated hereafter. Capitalized terms used but not defined in this Adoption Agreement shall have the respective meanings
ascribed to such terms in the Agreement. By the execution of this Adoption Agreement, the Holder agrees as follows.

 

1.1       Acknowledgement.
Holder acknowledges that Holder is acquiring certain shares of the capital stock of the Company (the “Stock”) or options,
warrants, or other rights to purchase such Stock (the “Options”), for one of the following reasons (Check the correct
box):

 

	 	☐	As a transferee of Shares from a party in such party’s capacity as an “Investor” bound by the Agreement, and after
such transfer, Holder shall be considered an “Investor” and a “Stockholder” for all purposes of the Agreement.
	 	 	 
	 	☐	As a transferee of Shares from a party in such party’s capacity as a “Key Holder” bound by the Agreement, and after
such transfer, Holder shall be considered a “Key Holder” and a “Stockholder” for all purposes of the Agreement.
	 	 	 
	 	☐	As a new Investor in accordance with Section 5.1(a) of the Agreement, in which case Holder will be an “Investor” and
a “Stockholder” for all purposes of the Agreement.
	 	 	 
	 	☐	In accordance with Section 5.1(b) of the Agreement, as a new party who is not a new Investor, in which case Holder will be a “Stockholder”
for all purposes of the Agreement.

 

1.2       Agreement.
Holder hereby (a) agrees that the Stock or the Options, and any other shares of capital stock or securities required by the Agreement
to be bound thereby, shall be bound by and subject to the terms of the Agreement and (b) adopts the Agreement with the same force and
effect as if Holder were originally a party thereto.

 

1.3       Notice. Any notice required or
permitted by the Agreement shall be given to Holder at the address or facsimile number listed below Holder’s signature hereto.

 

 

 

	HOLDER:	 	ACCEPTED AND AGREED:
	 	 	 
	By: ________________________	 	COMPANY
	Name and Title of Signatory	 	 
	 	 	 
	 	 	 
	Address: _________________________	 	By:
	 	 	 
	 	 	 
	________________________	 	Title:

 

 

 

    	 	13	 

     

    

 

EXHIBIT B

 

CONSENT OF SPOUSE

 

I, ____________________,
spouse of __________________, acknowledge that I have read the Voting Agreement, dated as of_____________,
to which this Consent is attached as 0 (the “Agreement”), and that I know the contents
of the Agreement. I am aware that the Agreement contains provisions regarding the voting and transfer of shares of capital stock of the
Company that my spouse may own, including any interest I might have therein.

 

I hereby agree that my interest,
if any, in any shares of capital stock of the Company subject to the Agreement shall be irrevocably bound by the Agreement and further
understand and agree that any community property interest I may have in such shares of capital stock of the Company shall be similarly
bound by the Agreement.

 

I am aware that the legal,
financial and related matters contained in the Agreement are complex and that I am free to seek independent professional guidance or
counsel with respect to this Consent. I have either sought such guidance or counsel or determined after reviewing the Agreement carefully
that I will waive such right.

 

 

 

 

 

_______________________________

________________________

 

Dated: ________________

 

 

 

    	 	14

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00339-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00339-of-00352.parquet"}]]